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MASPs are members of a multigenic family recently identified during the sequencing 
of the T. cruzi CL Brener genome. This family contains around 1,400 members, 
consisting of approximately 6% of the whole coding genes. Highly conserved N- and 
C-terminal domains, which encode a signal peptide and GPI-anchor addition site 
respectively, and a hypervariable central region, characterize MASPs. Members of 
this family are predominantly expressed in the infective trypomastigote form. We 
hypothesized that members of the T. cruzi MASP protein family play a major role in 
the interaction of the parasite with the host cell. In order to investigate a putative role 
for T. cruzi MASP at the host-pathogen interface, we have used MASP as a bait 
protein against the human proteome using a high-throughput platform that we have 
recently established for identifying protein-protein interactions between pathogens 
and theirs hosts.  Yeast two-hybrid screens identified human SNAPIN as one of two 
  
major MASP interacting proteins. SNAPIN is a member of the SNARE protein 
complex, which may have a role in a calcium-dependent exocytosis. The MASP-
SNAPIN interaction was further validated using  vivo co-Affinity Purification and 
in vitro pull-down assays. Immunofluorescence assays showed human SNAPIN is 
recruited to the parasite surface during invasion. Co-localization experiments 
indicated that SNAPIN is associated with the late endosomes and lysosomes.  
Supporting our initial hypothesis, SNAPIN depletion using siRNA oligomers in HeLa 
cells and snapin-/- in Mouse Embryonic Fibroblast (MEF) cells significantly inhibited 
T. cruzi invasion, suggesting a role for SNAPIN in this process. Lysosomes in snapin-
/- MEF cells displayed aberrant morphology and distribution and the parasites did not 
recruit host lysosomes efficiently when compared to wild-type cells. Thi was likely 
due to an impaired calcium-dependent lysosome exocytosis in napin-/- MEF cells. 
SNAPIN was translocated to the plasma membrane upon calcium influx induced by a 
calcium ionophore (Ionomycin), resulting in the exposure of the luminal domain of 
SNAPIN to the extracelluar space. Leishmania tarentolae transgenic strains 
expressing two different MASP proteins were shown to trigger intracellular ca cium 
transients in HeLa cells, presumably by injuring the cell membrane. We propose that 
T. cruzi MASP plays a role in wounding the plasma membrane of the host cell, which 
in turn elicits a transient intracellular calcium flux and leads to the translocation of 
lysosome-associated SNAPIN to the plasma membrane. Human SNAPIN, through its 
exposed luminal domain would then provide an anchor for the entry to the parasite 
into the cell. The mechanism of T. cruzi MASP evoked calcium influx in the host cell 
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Chapter 1: Introduction 
1.1 Trypanosoma cruzi and Chagas disease 
1.1.1 Trypanosoma cruzi 
Trypanosoma cruzi (T. cruzi) is a monoflagellated intracellular protozoan parasite and 
the etiological agent of Chagas disease or American trypanosomiasis. It wa  first 
identified by Dr. Carlos Chagas, a Brazilian physician, as the causative agent of the 
disease and named after his mentor, Oswaldo Cruz, in 1909. He characterized the 
transmission mode, the entire life cycle in vectors and other hosts Chagas discovery 
was a hallmark in the history of parasitology since he determined almost every asp ct 
of a new neglected tropical disease on his own. 
1.1.2 Genetic diversity in T. cruzi  
T. cruzi strains are classified into six discrete typing units (DTUs) from TcI to TcVI 
(Zingales, Andrade et al. 2009). It has been widely shown that the major lineages of T. 
cruzi exhibit significant differences in pathogenic potential (Tibayrenc 1995; Souto, 
Fernandes et al. 1996; Campbell, Westenberger et al. 2004). The reference genom
strain, CL Brener (TcVI), is a hybrid of TcII and TcIII. The recently sequenced strain 
Sylvio X10 belongs to TcI (Franzen, Ochaya et al. 2011). The genomic comparative 
study revealed that the two strains TcI and TcVI representing different DTUs are 
virtually identical even though their geographical distribution is quite different. TcI 
strain predominates North of the Amazon and causes heart disease whereas TcVI 




disease as well as mega syndromes in the colon and esophagus (Vago, Andrade et al. 
2000; Coura 2007; Coura and Dias 2009; Rassi, Rassi et al. 2010). It is speculated 
that the heterogeneity of T. cruzi strains could be behind the different clinical 
manifestations of Chagas disease (Macedo, Machado et al. 2004). Further sequencing 
of T. cruzi strains and a subsequent comparison will allow the discovery of the 
genetic basis responsible for divergent phenotypes such as cell cycle, host range, 
vector selection, pathogenic and clinical manifestations.  
1.1.3 Transmission 
T. cruzi has three distinct morphologies depending on its host environment: the 
epimastigote, the trypomastigote and the amastigote (Urbina 1999). The epimastigote 
is a replicative form of T. cruzi that resides in the insect vector. The metacyclic 
trypomastigote (MT) is the infective but non-replicative form of T. cruzi found in the 
hindgut of the insect vector and the trypomastigote is the infective and bloodstream 
form. Lastly, the amastigote is an intracellular form of T. cruzi, replicative and often 
invasive. Structurally, the three forms of the T. cruzi are most easily distinguished by 
the relative location of nucleus and kinetoplast DNA. The kinetoplast DNA is located 
anterior to the nucleus in the epimastigote while in the trypomastigote the nucleus is 
centrally positioned and kinetoplast DNA is located towards the posterior.  
T. cruzi has a life cycle alternating between vertebrate hosts and invertebrate hosts. 
The insect vector, Triatomine bugs (the Reduviidae family, Triatominae sub-family), 
typically transmits T. cruzi through the feces or urine during a bloodmeal. The three 
main domestic vectors are Rhodnius prolixus, Triatoma dimidiata, nd Triatoma 




soft facial skin. These Triatomine bugs can deliver T. cruzi to more than 150 species 
of animal hosts generating an immense animal reservoir of disease. The rate of 
infection after contact with an infected triatomine bug is estimated to be about one in 
a thousand people (Rabinovich, Mogilevskii et al. 1990).  
Metacyclic trypomastigotes present in excreta can enter the broken skin when the 
mammalian host rubs or scratches near the bite site and then reach underlying cells. 
The trypomastigote hijacks the host cellular processes and actively invades nearly a y 
nucleated cells. Once inside the cell they transform into the amastigote form, divide 
nine times (one trypomastigote produces around 500 amastigote in 5 days), 
redifferentiate into trypomastigotes and eventually rupture the cell (Carranza, 
Kowaltowski et al. 2009; Carranza, Valadares et al. 2009; Mazzarotto, Pristipino et al. 
2009). Released T. cruzi trypomastigotes can infect neighboring cells or circulate in 
the bloodstream and get transferred back to the insect vector during a blood meal 
where they transform into epimastigotes, the non-infective and reproductive form o  T. 
cruzi (Figure 1-1) (Tyler and Engman 2001). 
The insect vector-mediated transmission can occur in the Americas extending from 
the South of the United States to Argentina where competent vectors reside. T. cruzi
can be transmitted in non-endemic areas as a result of traveling and migration of 
infected individuals from endemic countries or organ donation/blood 
transfusion/vertical transmission (Schofield, Jannin et al. 2006; Tobler, Contestable e  
al. 2007; Young, Losikoff et al. 2007; Bern and Montgomery 2009).  Hence, Chagas 






Figure 1-1. Life cycle of Trypanosoma cruzi. Cell invasion of the skin by infective 
trypomastigotes after host scratch near the bite site is followed by transformation into 
amastigotes and multiple binary divisions in the cell cytoplasm. Upon the rupture of 
the cell, released trypomastigotes can either invade other cells or get picked up by the 






Figure 1-2. Chagas disease distribution and migration route from South 
America to the non-endemic region (a total number of infected individuals). 
Infected population in endemic region is indicated in light grey and other infected 















1.1.4 Chagas disease 
1.1.4.1 Epidemiology and public health concern 
Chagas disease is endemic in 21 countries to South America. It is estimated that 10 
million people are currently infected worldwide, including 300,000 people in the 
United States. 25-90 million people are at risk for infection. Every year, 109,000 new 
infections occur and 11,000 people die from Chagas disease mainly due to heart 
complication symptoms during the late stage of the disease (WHO 2002; Hotez, 
Bottazzi et al. 2008; Bern and Montgomery 2009). The economic burden of Chagas 
disease in South America is immense and this includes unemployment and reduced 
earning ability estimated at 667,000 disability-adjusted life years (DALY). In Brazil 
alone, losses of over $1.3 billion were estimated and attributed to the workers with 
Chagas disease (WHO 2010). 
 
1.1.4.2 Progression 
1.1.4.2.1 Acute phase 
Chagas disease presents three clinical phases: acute phase, indeterminate phase and 
chronic phase. The acute phase follows the initial infection by T. cruzi and lasts 4-6 
weeks. The entry site is often marked by immediate inflammation of the area and the 
typical swelling in the conjunctiva of the eye, which is referred to as Romaña's sign. 
During the acute phase, high blood parasitaemia is detected and every nucleated cell 
in the host is a target for infection. This phase is characterized by mild symptoms 
such as fever, swelling of lymph nodes and tissues, and malaise. In most cases, it is 




Ironically, this is the only stage where effective treatments are available using the 
trypanocidal drugs benznidazole and nifurtimox (Villar, Marin-Neto et al. 2002; 
Wilkinson and Kelly 2009). In fact, even without trypanocidal drug treatment, the 
acute infection spontaneously resolves in the vast majority of patients. After the host 
adaptive immunity kicks in, the number of parasites in the blood and tissues 
significantly declines and it enters the indeterminate phase (Rassi, Ra et l. 2010). 
Complications during the acute phase are usually seen in children where 2-8% of 
symptomatic child patients may die due to cardiac failure (Prata 2001). 
1.1.4.2.2 Indeterminate phase 
The acute phase is followed by an asymptomatic indeterminate phase. Around 60-70% 
of patients that progress from the acute phase never develop the chronic symptoms 
and remain in this phase for life (Macedo 1999). The indeterminate phase is defined 
by continued positive serology and subpatent parasitaemia but no evidence of organ 
abnormality (Macedo 1999). One out of three carriers progress to the chronic phase, 
which can be the first time the individual is diagnosed with Chagas disease even 
though T. cruzi parasites may have persisted for decades (Teixeira, Nitz et al. 2006). 
It is speculated that host genetic susceptibility may play a role in why a minority of 
individuals in the indeterminate phase develops chronic Chagas disease while the rest 
remain in the indeterminate phase.  
1.1.4.2.3 Chronic phase 
The chronic phase of the T. cruzi infection is characterized by cardiac and 




malfunction, mega syndrome and sudden cardiac arrest (Rassi, Rassi et al. 2000; 
Rassi, Rassi et al. 2001).  The chagasic cardiomyopathy is the most common cause of
death by heart failure during the chronic phase in South America. Both fibrosis and 
cell apoptosis by parasite persistence as well as amastigotic cyst forma ion in the area 
lead to disruption of heart electronic conduction system and eventually myocardial 
cell loss (Tostes, Bertulucci Rocha-Rodrigues et al. 2005). Enlargement of the heart is 
common as well. The only option available at this phase is a heart transplant. 
Another main pathology associated with this chronic phase is often referred to as 
“megasyndromes”, specifically megaoesophagus and megacolon. Those are less
common than the cardiac symptoms of Chagas disease but more dramatic. 
Amastigotic cysts in digestive organs, the colon or the esophagus, damage nerves thus 
decreasing the ability of smooth muscle to dilate and contract. The loss of this activity 
causes a loss of rigidity and an enlargement of organs. This involvement of the 
nervous system is another hallmark of the chronic phase of Chagas disease. 
Megaesophagus and megacolon can result in death due to malnutrition. 
 
1.1.4.3 Chagas disease pathogenesis 
The pathogenesis of Chagas disease is controversial. Two generally accepted 
hypotheses are autoimmunity (Leon and Engman 2001) and parasite-persistence 
(Tarleton 2001). The autoimmunity model is based on the observation of 
inflammatory cells and T. cruzi-induced disease symptoms in tissues even in the 
absence of the apparent intracellular parasites. The traditional diagnostc methods 




from blood-fed triatomine bugs often fails to detect T. cruzi in the blood of chronic 
Chagas patients. This led people to propose a model of autoimmunity that was 
originally initiated by the parasite but eventually the host immune system begins to 
attack its own tissues even after parasite clearance (Cunha-Neto, Duranti et al. 1995; 
Cunha-Neto and Kalil 1995). However, the emergence of more sensitive 
immunohistochemical and polymerase chain reaction (PCR)-based diagnostic test  
questions the autoimmunity model by demonstrating the parasites’ persistence de p 
inside the tissues including myocardium. The parasite persistence is notably 
supported by the successful treatment of infected patients with trypanocidal drugs. 
The recent advances in clinical trials have put significant weight to the parasite-
persistence model (Zhang and Tarleton 1999; Gutierrez, Guedes et al. 2009) although 
the autoimmunity model cannot be ruled out completely.  
 
1.1.4.4 Prevention and treatment 
Chagas disease control attempts in South America have focused mainly on vector 
control along with public campaigns to raise awareness (Petherick 2010). Vector
eradication programs were organized by the Pan American Health Organization 
(PAHO) as well as multinational initiatives such as the Southern Cone Initiative (SCI), 
which included a number of countries such as Argentina, Belize, Bolivia, Brazil, 
Chile, Colombia, Costa Rica, Ecuador, El Salvador, Guatemala, Honduras, Nic ragua, 
Panama, Peru, Uruguay and Venezuela.  These programs have been very successful 
and the efforts of SCI ceased transmission in Uruguay, Chile and large parts of Brazil 




Vazquez-Prokopec, Spillmann et al. 2009). However, the disease is still prevalent in 
some areas in South America such as the Gran Chaco, a sparsely populated region 
covering mainly Bolivia, Paraguay and Argentina where one out of sixteen people is 
infected (Hotez, Bottazzi et al. 2008). 
Despite the intensive effort to identify the potential vaccine candidates, no vaccines 
are currently available for Chagas disease (Garg and Bhatia 2005; Dumonteil 2007). 
The only existing options have been the two drugs, nifurtimox and benznidazole, 
since the 1960s (Castro and Diaz de Toranzo 1988). However, they are effective in 
the early acute phase when administered for 60 days at the correct dose but not in the 
chronic phase (Urbina 1999). These drugs also display severe side effects (Croft 1999; 
Tarleton, Reithinger et al. 2007). Furthermore, parasite resistance to the drugs was 
reported (Wilkinson, Taylor et al. 2008), prompting needs to identify additional drugs. 
Nifurtimox works on the nitroreductase in T. cruzi and can be used to treat T. brucei 
as well. It generates a nitroanion, which is a radical anion leading to the formati n of 
reactive species that T. cruzi fails to remove (Wilkinson, Taylor et al. 2008; Cerecetto 
and Gonzalez 2011). Benznidazole creates a covalent bond with various parasite 
components and eventually inhibits the parasitic redox (reduction/oxidation) 
processes. It is very urgent to develop vaccines and drugs to prevent and cure the 
Chagas disease and a fundamental understanding of pathological mechanism of 







1.2 The cell and molecular biology of host cell invasion 
1.2.1 Host cell invasion by trypomastigotes 
T. cruzi is the only parasite among the Tritryps, three related trypanosomes, which 
can actively invade any nucleated host cells (Burleigh and Andrews 1995; Alves and 
Colli 2007; Yoshida and Cortez 2008), whereas T. brucei resides in the bloodstream 
extracellularly and L. major is passively phagocytosed by macrophages. T. cruzi 
mammalian host cell invasion has been extensively studied in vitro using non-
professional phagocytic cells since chronic Chagas disease is characterized by the 
persistence of parasites in muscle tissues. In 1992, a very unique mechanism for T. 
cruzi invasion was described and generally accepted as a major cell entry pathway 
(Tardieux, Webster et al. 1992). This invasion mechanism exploits the host lysosome 
in a manner that is quite different from those previously described for other 
intracellular microbes. T. cruzi trypomastigote invasion does not seem to involve 
phagocytosis since no evidence of actin polymerization or the formation of a 
phagocytic cup surrounding the invading trypomastigote were found (Schenkman, 
Robbins et al. 1991; Tardieux, Webster et al. 1992). Cytochalasin D, an actin 
polymerization and phagocytosis inhibitor, promotes the T. cruzi invasion process 
supporting the fact that parasites gain entry to host cells in a non-phagocytic 
mechanism (Schenkman, Robbins et al. 1991; Tardieux, Webster et al. 1992). This is 
very intriguing considering the size of the trypomastigotes (~15 µm long), the driving 
force promoting the fairly big parasite internalization was elusive if it is not host cell 
actin polymerization. It was later shown that host lysosomes were recruited to he 












Figure 1-3. T. cruzi host cell invasion. (A) T. cruzi invades the host cell exploiting a 
calcium-dependent lysosome recruitment along the micrutubule and fusion to the 
plasma membrane and depolymerization of actin filaments. (2003 Gruenheid t al. 
Nature) (B) T. cruzi enters the cell in two ways. The major entry mechanism is 
mediated by lysosome recruitment and but T. cruzi can get internalizaed by plasma 
membrane invagination followed by lysosome fusion. (2005 Burleigh t al.Sci STKE) 
(C) Plasma membrane repair mediated by a calcium-regulated lysosomal exocytosis 
followed by complement endocytosis caused by the enzyme ASM is a housekeeping 










(Tardieux, Webster et al. 1992). T. cruzi invasion was also significantly reduced upon 
treatment with the drugs, colchicine and vinblastine that disrupts microtubule 
formation (Rodriguez, Samoff et al. 1996), presumably by inhibiting the recruitment 
of host lysosomes to the plasma membrane where the trypomastigote penetrates 
(Figure 1-3 A) (Tyler, Luxton et al. 2005). A recent study also suggests that host 
autophagosomes may be able to replace the role of lysosomes in T. cruzi invasion 
(Romano, Arboit et al. 2009). After host cell entry, the T. cruzi trypomastigote stays 
in a host lysosome-derived parasitophorous vacuole, which is a required event for the 
successful cell invasion (Andrade and Andrews 2004), and eventually escapes from 
the parasitophorous vacuole into the cytosol where it starts differentiation into the 
amastigote form and then replicates. It is well established that cells inge t small 
molecules through clathrin-mediated endocytosis whereas large particles are 
phagocytosed driven by an actin polymerization (Kaplan 1977). The lysosome-
dependent invasion mechanism for T. cruzi trypomastigote was a novel discovery 
(Tardieux, Webster et al. 1992). Subsequently, lysosome recruitment was found not 
to be the only way T. cruzi trypomastigote could enter the cell. T. cruzi can also 
invade the host cells by being engulfed by invaginated plasma membrane and 
subsequently fusing with lysosomes. This pathway appears to be host cell actin-
independent, another characteristic that differentiates it from traditional phagocytosis 
(Figure 1-3 B) (Woolsey, Sunwoo et al. 2003). The amastigote, the intracellular form 
of T. cruzi, was also shown to be infective as it was observed that amastigotes were 
taken up by monocytes almost readily and even by non-professional phagocytic cells 




mechanism is presumed to be traditional phagocytosis. Once inside the host cell, the 
amastigote behaves the same as trypomastigote but readily starts binary division after 
being release into cytosol. 
1.2.2 The role of host lysosomes in T. cruzi invasion 
Experiments using the fluorescent calcium sensor Fluo-3 revealed that T. cruzi 
trypomastigotes trigger transient intracellular calcium increase thus leading to 
subsequent calcium-dependent lysosomal exocytosis (Tardieux, Nathanson et al. 
1994). It was shown that calcium transients were required for T. cruzi trypomastigote 
invasion since depletion of calcium reduced the host lysosome recruitment to the 
plasma membrane and thus T. cruzi invasion rate (Tardieux, Nathanson et al. 1994). 
As stated earlier, it was proposed that T. cruzi trypomastigote can gain entry into the 
host cell either by lysosome-mediated pathway or plasma membrane-mediated 
pathway. T. cruzi trypomastigotes were able to successfully invade host cells treated 
with Wortmannin, an inhibitor of phosphoinositide 3-kinases (PI3Ks), where 
lysosome-dependent pathway was blocked, demonstrating that another invasion 
mechanism exists (Woolsey, Sunwoo et al. 2003). Interestingly, the subsequent work 
has shown T. cruzi inside the host cell should reside in the lysosome-derived 
parasitophorous vacuole regardless of the host cell invasion mechanisms (Andrade 
and Andrews 2004). The failure to reside within a parasitophorous vacuole after 
invasion results in the escape of T. cruzi to the extracellular space, indicating the 
importance of the microtubular network within the cell for T. cruzi cellular retention. 
This observation suggests that host lysosome fusion is required for the viable 




parasitophorous vacuole, which seems to initiate the differentiation program from the 
trypomastigote to amastigote. Trypomastigotes in the parasitophorus vacuole 
facilitate their own escape by secreting TcTox, a hemolysin forming a pore active at 
low pH, on the vacuolar membrane and by removing sialic acids from lysosomal 
glycoproteins on the vacuolar membrane with trans-sialdase (Andrews 1990; 
Andrews, Abrams et al. 1990). Upon disruption of the parasitophorous vacuole, 
intracellular amastigotes asexually divide nine times until they redifferentiate to 
trypomastigotes (Figure 1-4). 
1.2.3 The role of glycoprotein 82 in calcium transients. 
Calcium-regulated lysosomal exocytosis seems to be the major mechanism that T. 
cruzi trypomastigotes exploit for cell entry (Burleigh 2005) and it was shown that T. 
cruzi trypomastigotes trigger calcium transients in the host cells (Tardieux, 
Nathanson et al. 1994). Further studies demonstrated that similar calcium transien s 
also occur within the invading trypomastigote and these calcium transients in both 
host cells and the trypomastigote are required for invasion (Moreno, Silva et al. 1994; 
Yakubu, Majumder et al. 1994). Glycoprotein 82 (GP82) was found to be responsible 
for these calcium transients (Manque, Neira et al. 2003). Endogenous GP82 is 
expressed in the metacyclic trypomastigote stage, the infective form of T. cruzi, and 
when GP82 is overexpressed in epimastigotes, the non-infective insect forms of T. 
cruzi, transgenic parasites were able to induce calcium transients in the host cells. 
However, the receptor for GP82 on the host cell is not identified. Calcium transients 






Figure 1-4. T. cruzi host cell invasion process. 1) Trypomastigotes catalyze host 
sialic acid to mucins on the parasite surface by trans-sialidase for efficient entry. 2) 
Phospholipase C-mediated intracellular calcium increase in the host cytoplasm due to 
the release from the internal stores occurs by parasite surface protein GP82. 3) 
Calcium transients lead to host lysosomal exocytosis and the trypomastigotes are 
internalized. 4) Trans-sialidase on the parasite transfers sialic acids from host 
lysosomal glycoproteins and the secreted TcTox forms a pore on the vascuolar 




eventually lysed. 5) Trypomastigotes start differentiation into amastigotes, which 
replicate multiple times in the cytoplasm. 6) After redifferentiation into 
trypomastigotes, trypomastigotes and few immature amasitigote gets relea ed the 






















phosphorylation although the exact mechanism remains largely unclear. Other 
trypomastigote glycoprotein molecules that could possibly trigger calcium transient in 
the host cells include GP35/50 and GP90 but the induction by both glycoproteins are 
negligible compared to GP82 (Ruiz, Favoreto et al. 1998).   
1.2.4 Membrane repair and T. cruzi invasion 
Other studies suggest that this unusual calcium-dependent lysosome-mediated 
exocytosis being exploited by T. cruzi may be a housekeeping mechanism in 
mammalian cells (McNeil and Steinhardt 1997; Reddy, Caler et al. 2001; Idone, Tam 
et al. 2008). It was shown that plasma membrane repair requires calcium-dependent 
exocytosis of lysosomes followed by endocytosis to get rid of membrane lesions 
(Idone, Tam et al. 2008). Further analysis revealed that lysosomal enzyme acid 
sphingomyelinase (ASM) is secreted as a result of calcium-dependent lysosomal 
exocytosis when cells are injured and converts plasma membrane sphingomyelin into 
ceramide (Schissel, Jiang et al. 1998; Tam, Idone et al. 2010). Ceramides on the 
plama membrane associate themselves into microdomains that generate endosom s 
and promote the complement endocytosis for plasma membrane lesion internalization 
(Holopainen, Medina et al. 2000; Gulbins and Kolesnick 2003). ASM-deficient cells 
were unable to repair the wounding caused by bacterial pore forming toxin, SLO, but 
the restoration of plasma membrane repair was observed when the recombinant ASM 
proteins were added exogenously indicating this lysosomal enzyme reseals the plasma 
membrane and maintain the plasma membrane integrity by removing membrane 




More recently a study revealed that T. cruzi host cell entry mimics the same process 
(Fernandes, Cortez et al. 2011). T. cruzi trypomastigotes, but not epimastigotes, can 
directly wound the plasma membrane by unknown mechanism and trigger cytosolic 
calcium transients. Elevation of the intracellular calcium concentration induces the 
exocytosis of lysosomes and the release of host lysosomal enzyme ASM to the outer 
leaflet of the plasma membrane. Again, a rapid complement endocytosis resealthe 
injury site by internalization and T. cruzi gain entry into the cell taking advantage of 
the endocytosis near the wounding site. The depletion of ASM representing the 
plasma membrane non-repair condition in the host cell significantly reduces the T. 
cruzi invasion rate whereas the addition of recombinant ASM restores the host 
endocytosis as well as the T. cruzi invasion rate in ASM-deficient cells. This also 
demonstrated that tissue tropism with the preference of cardiomyocytes and smooth 
muscle cells may be related to the fact that these tissues are susceptible to injury, and 
thus is easier to invade. However, the exact molecule(s) responsible for the injury on 
the membrane triggering the calcium transients remain unclear (Figure 1-3 C). 
1.3 Genome sequencing of T. cruzi CL Brener reference strain 
The sequencing of the T. cruzi genome was completed and published in 2005 
along with the sequenced genome of two other trypanosomatids human 
parasites: Typanosoma brucei and Leishmania major (Berriman, Ghedin et al. 2005; 
El-Sayed, Myler et al. 2005; Ivens, Peacock et al. 2005). The genomes of these thre  
model trypanosomatids (also referred to as TriTryps) were sequenced, assembled, and 
then genes were predicted, annotated and compared to each other by reciprocal blast 




surprisingly conserved gene synteny between the three species, despite the ancient 
divergence (200-500 millions of years ago) indicating very strong selective pressure 
the gene order and orientation. The set of gene clusters shared by the TriTryp species, 
also known as the TriTryp core, has 6,157 gene members and represents a valuable 
opportunity in terms of possible drug targets that can affect the three organisms at the 
same time (El-Sayed, Myler et al. 2005). The fact that roughly 2,000 out of those 
6,157 core genes are not present in the human host makes the potential 
chemotherapeutic approach more viable. In addition, the genome analysis revealed 
that many species-specific genes clusters encode for proteins responsible for the 
distinct nature of the disease: different strategies of survival and immune evasion 
used in each organism (Figure 1-5 B). 
The genome size of T. cruzi is around 100 Mb with 12,000 genes in the haploid 
genome of the CL-Brener strain. One of the unique features of the T. cruzi genome 
over T. brucei and L. major is the massive expansion of T. cruzi-specific surface 
protein gene families such as Mucins, trans-sialidase (TS) / GP85 and DGF-1 which 













Figure 1-5. Tritryp comparative genomics.  (A) A physical arrangement of the 
Tritryps genomes revealing a conserved synteny as well as synteny breaks mainly in 
subtelomeric regions (Red : Leishmania major, Purple : Trypanosome brucei, Blue : 
Trypanosome cruzi) (B) A Venn diagram comparing the gene contents of the Tritryps 
and depicting a core proteome of the Tritryps and species-specific proteins (2005 El-





1.4 Multigenic families in T. cruzi 
1.4.1 Trans-sialidases and GP85 
Trans-sialidases (TS) are members of the largest multigenic family in T. cruzi 
consisting of 1430 members including 693 pseudogenes. Similar to T. brucei, T. cruzi 
lacks the sialic acid biosynthesis pathway components in the genome (El-Sayed, 
Myler et al. 2005). T. cruzi expresses trans-sialidase, a protein that transfers sialic 
acid residues from host glycoconjugate to T. cruzi mucins (Schenkman, Jiang et al. 
1991; Ferrero-Garcia, Trombetta et al. 1993) (reviewed below). Unlike a 
conventional sialidase located at the Golgi apparatus, it is located on the surface of T. 
cruzi, thus making it much more efficient in terminal sialic acid transfer (Buscaglia, 
Campo et al. 2006; Agusti, Giorgi et al. 2007). TS expression is coordinated with T. 
cruzi mucin due to its associated genomic location indicating the possible interplay 
between TS and mucin (Buscaglia, Campo et al. 2006). TS is also GPI-anchored to 
the plasma membrane of T. cruzi and can be shed into the bloodstream by 
endogenous phosphatidylinositol-phospholipase C (PI-PLC) inducing different 
biological effects by altering the sialylation profile on the host cell surface. Among 
more than 1400 members, only around 70 members are enzymatically active and 
most of active TSs contain SAPA (shed acute-phase antigen) (Cazzulo and Frasch 
1992). Another set of 70 members share more than 95% identity with active TS but 
they are enzymatically inactive due to a point mutation in a key residue, Tyrosine 342 
(Buschiazzo, Amaya et al. 2002). These inactive TS members can still bind to sialic 
acids, however, indicating that they may play a role in cell adhesion despite the loss 




genes sharing a sialidase motif (VTVxNVxLYNR) have more or less 30% identity to 
active TS thus are inactive (El-Sayed, Myler et al. 2005; Tonelli, Giordano et al. 
2010). This suggests that there is a strong selective pressure on the TS superfamily to 
achieve this diversity. Furthermore, TS seems to play a role in the escape of T. cruzi 
from the parasitophorous vacuole and it is speculated that the sialylation during this 
process protects T. cruzi from a rapid acidification of the parasitophorous vacuole by 
lysosome fusion events (Frasch 2000). Also the removal of sialic acids from 
lysosomal glycoproteins on the parasitophorous vacuole may make the 
parasitophorous vacuole membrane more susceptible to TcTox and eventually lead to 
loss of membrane integrity (Andrews 1990). TS-mediated sialylation in 
trypomastigotes mucin also protects T. cruzi from the complement pathway in the 
host by binding to complement factors C3b and C4b and triggering their inactivation 
by protease activity although this protease is not fully characterized (Figure 1-6) 
(Tomlinson, Pontes de Carvalho et al. 1992; Mucci, Risso et al. 2006). GP85 is a non-
catalytic member of the TS superfamily, known to bind to laminin and cytokeratin 18 
(Giordano, Chammas et al. 1994), indicating it is involved in the T. cruzi adhesion to 
the host cell surface and thus very important for T. cruzi invasion process.    
1.4.2 Mucins 
The surface of T. cruzi contains other major surface glycoproteins including mucins, 
which are heavily O-glycosylated molecules important in cell-cell interac ions. The T. 
cruzi mucin gene family comprises 863 members corresponding to around 1% of the 





Figure 1-6. Trans-sialidase in
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The mucin gene repertoire shows greater genetic diversity than that of the trans-
sialidases (TS) in terms of its complexity (Frasch 2000; Eugenia Giorgi and de 
Lederkremer 2011). T. cruzi mucins were named after mammalian mucins, due to 
their sequence similarity (Eugenia Giorgi and de Lederkremer 2011). The mucins on 
the surface of the T. cruzi are anchored to the outer leaflet of the plasma membrane 
through a glycosylphosphatidylinositol (GPI) anchor. The extensive O-glycosylation 
on mucin accounts for almost 60% of the molecular mass (Almeida, Ferguson et al. 
1994; Previato, Jones et al. 1994; Buscaglia, Campo et al. 2006). Mucins are 
expressed throughout the T. cruzi life cycle (Buscaglia, Campo et al. 2006). 
Depending on the host environment, different mucins are expressed such as TcSMUG 
and TcMUC families. The TcSMUG family is relatively small in number (19 
members) and size (35-50 kDa), homogenous and expressed in the epimastigote, the 
insect form of T. cruzi. However, TcMUC group I and II are much larger in number 
(844 members) and size (60-200 kDa) and expressed in the vertebrate stage. TcMUC 
group I and II were classified by repetitive and non-repetitive central regions (Di 
Noia, Buscaglia et al. 2002).  The unique feature of TcMUC group II is its genomic 
location in subtelomeric region along with TS genes. Considering the polycistronic 
transcription in T. cruzi, there may be an important interplay between TS and Mucins 
(Campo, Buscaglia et al. 2006). Within the same large cluster of TS and TcMUC 
group II, a novel large T. cruzi-specific gene family was identified and they were 
frequently found downstream of TcMUC group II so the family was named mucin-





Figure 1-7. T. cruzi mucins during life cycle.
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One of the key functions of mucin, especially TcMUC group II, is the role as the 
acceptors of sialic acid (SA) from the host cell glycoconjugate (Buscaglia, Campo et 
al. 2006). Even though T. cruzi have several glycosyltransferases, it is unable to 
biosynthesize sialic acid. Instead they can utilize GPI-anchored TS and transfer sialic 
acid from the host sialoglycoconjugates to the terminal β–galactose on the highly O-
glycosylated TcMUC group II. This ability is important for T. cruzi to invade the host 
cells and to escape from the parasitophorous vacuole. Also a thick layer of mucin on 
the surface is speculated to contribute to the parasite protection from complement-
mediated lysis and improve the adhesion of T. cruzi to the host extracellular matrix. T
cruzi mucin does not have orthologs in other trypanosomes, Trypanosoma brucei and 
Leishmania major. It is noteworthy that the O-linked chains are connected to the 
protein by α–GlcNAc instead of α–GalNAc found in the majority of mammals 
(Eugenia Giorgi and de Lederkremer 2011). This unusual feature can help design 
drugs and target T. cruzi mucin specifically (Figure 1-7). 
1.4.3 DGF-1 
Dispersed Gene Family-1 (DGF-1) members constitute the fifth largest gene family in 
T. cruzi genome, consisting of 565 genes (El-Sayed, Myler et al. 2005).  It is the third 
largest among T. cruzi-specific large gene families after MASP and mucin. The vast 
majority of this gene family is found in subtelomeric regions along with 
retrotransposon hotspot (RHS) proteins, transsialidases and many retroelements such 
as VIPER/SIRE and DIRE (El-Sayed, Myler et al. 2005).  DGF-1 proteins harbor 
conserved adhesion motifs and they are localized on the surface of T. cruzi 




extracellular matrix protein such as fibronectin and laminin. In contrast, one of th se
proteins (DGF-1.2) was reported to localize intracellularly in different life cycles of T. 
cruzi and to be more abundant in amastigotes than epimastigotes or trypomastigotes 
(Lander, Bernal et al. 2010). DGF-1.2 was also detected in the culture medium 
indicating some level of secretion. The high copy number of this gene family in T. 
cruzi genome strongly implicates the importance of its role in T. cruzi biology but the 
putative function of DGF-1 gene family remain largely unknown.  
1.4.4 MASP (mucin-associated surface protein)  
The comparative analysis also includes a major discovery f a 1,377-gene family 
encoding the novel mucin-associated surface proteins (MASP). Despite its large size 
(the largest T. cruzi-specific multigenic family representing 1% of the whole diploid 
genome and 6% of the coding genes), the masp family has not been characterized to 
date. Many large gene families that encode surface antigens including MASP 
are clustered mainly in large, nonsyntenic subtelomeric regions that include trans-
sialidase (TS) superfamily, RHS and DGF-1. Within these large clusters, masp genes 
are preferentially located downstream of mucins, especially TcMUC group II genes 
and so were named mucin-associated surface proteins although MASP and TcMUC 
group II only resemble each other in structure not in sequence (Figure 1-10) (El-
Sayed, Myler et al. 2005; Bartholomeu, Cerqueira et al. 2009). MASP members 
contain N- and C-terminal conserved domains that encode a putative signal peptide 
and a GPI-anchor addition site respectively. The central region is variable both in its 
length and contents, and contains a large repertoire of repetitive motifs (Figure 1-9 A). 




conserved 5' and 3' untranslated regions (UTRs) (Figure 1-8 A). Western blots of 
phosphatidylinositol specific phospholipase C (PI-PLC)-treated parasites suggest that 
MASP is GPI-anchored and can be cleaved upon PI-PLC treatment. The presence of 
MASP in the culture medium even without PI-PLC treatment indicates that MASP 
can be shed or secreted into the bloodstream.  MASP transcripts were preferentially 
expressed during the trypomastigote (bloodstream form) stage (Figure 1-8 B). 
Interestingly, despite the large number of genes, an ex mination of the expression 
profile of masp using trypomastigote cDNA library reveals that a subset of 
masp members is preferentially expressed in a parasite population at a specific time 
point, demonstrating that multiple masp members can be expressed in a population 
unlike VSG proteins in T. brucei and that the expression is biased toward a subset of 
members that might depend on the host cells. MASP protein was also predominantly 
expressed in the trypomastigotes, confirming its differential expression and the 
regulation of the MASP family during the life cycle (Figure 1-9 B). 
Immunofluorescence assay revealed the subcellular location of MASP to surface of 
the T. cruzi as expected presumably by GPI-anchor (Figure 1-9 C). MASP proteins 
were predicted to have multiple N- and O-glycosylation sites based on in silico 
analysis. Extensive posttranslational modifications of MASP, including possible 
heavy glycosylation, may explain why MASPs were not previously discovered using 
proteomic approaches (Atwood, Minning et al. 2006; Parodi-Talice, Monteiro-Goes 






Figure 1-8. MASP mRNA transcript features. (A) Alignment of all 771 MASP 
full-length transcripts. The coding region is represented by a red box and the UTRs 
by black lines (B) Northern blot analysis with total RNA isolated from epimastgotes, 
E, trypomastigotes, T and amastigotes, A probed with the conserved 3’ UTR region 

















Figure 1-9. MASP protein features. (A) All 771 MASP protein sequence alignment 
using ClustalW algorithm. (B) Western blot analysis of total protein extracts from the 
epimastigote, E, and trypomastigote, T, forms using anti-MASP peptide 7 antibodies 
(C) IFA assay of trypomastigotes incubated with anti-MASP peptide 7 antibodies 
(Red), nucleus and kinetoplastid DNA were stained with DAPI (Blue) (Bartholomeu 






Figure 1-10. Sequence similarity between multigenic families in T. cruzi. 
Multidimensional scaling plot representing the matrix of distance among the 
sequences derived from the N- (right panel) and C-terminal (left panel) conserved 
domains from MASP (yellow), TcMUCI (dark gray), TcMUCII (orange), TcMUCIII 
(pink), TcSMUGS (light gray), TcSMUGL (red) and SAP genes (turquoise) 













Recently, MASP52, a 52-kDa protein secreted from the trypomastigote form of T. 
cruzi, was identified and characterized that it is involved in T. cruzi infectivity as IgG 
antibodies against the catalytic region of MASP52 protein decreased the T. cruzi 
invasion rate and the MASP52-coated bentonite particles were phagocytosed by the 
host cells (De Pablos, Gonzalez et al. 2011). Using the antibodies against the signal 
peptide of this masp family, a differential expression of MASP during the T. cruzi life 
cycle was confirmed as previously described (Bartholomeu, Cerqueira et al. 2009). 
Interestingly MASP52 was found in the culture medium only when T. cruzi were 
incubated with the host cells indicating the shedding or secretion of MASP is 
promoted by the interaction with the host cells. 
1.4 SNAPIN 
SNAPIN was originally identified in 1999 as a neuronal SNAP-25-binding protein by 
a yeast two-hybrid screen of a human brain cDNA library using SNAP-25 as bait 
(Ilardi, Mochida et al. 1999). Later it turned out SNAPIN not only binds to SNAP-25 
but so does its ubiquitously expressed homolog SNAP-23 indicating that SNAPIN 
might be a general component of the SNARE (Soluble NSF Attachment Protein 
Receptor) machinery not necessarily in limited to neuronal cells (Buxton, Zhag et al. 
2003). SNAPIN is a 136 amino acid protein that is characterized by an amino-
terminal hydrophobic domain, a potential transmembrane domain and a carboxyl-
terminal coiled-coil domain (Gowthaman, Silvester et al. 2006). SNAPIN mediates 
the activation of synaptotagmin, the calcium sensor in the regulation of 
neurotransmitter release and enhances the association of synaptotagmin to the 




complex (Chheda, Mochida et al. 1999). The interacting domain of SNAPIN to 
SNAP-25 and SNAP-23 proteins was determined to be the coiled-coil domain in the 
carboxyl-terminus.  The peptide of this domain blocks the binding of full-length 
SNAPIN to SNAP-25 and SNAP-23 and thus reduces synaptic transmission. 
SNAPIN activity is regulated by phosphorylation specifically at serine 50 by Protein 
Kinase A (PKA) (Thakur, Stevens et al. 2004).  When this serine was mutated to an 
aspartic acid (S50D), a constitutive mutant, the association with SNAP-25 was 
increased whereas serine to alanine (S50A), a dominant negative mutant, showed 
reduced vesicle-mediated neurotransmitter release event. The study using SNAPIN 
knockout mice demonstrated that calcium-dependent exocytosis in chromaffin cells 
was significantly decreased (Tian, Wu et al. 2005) possibly due to the critical 
function of SNAPIN in priming large dense-core vesicles for fusion to neuronal 
plasma membrane and in facilitating synchronized fusion of synaptic vesicles in 
neurons (Pan, Tian et al. 2009). More recently, it was suggested that SNAPIN is 
involved in the late endosome transport and lysosome maturation by interacting with 
dynein motor complex and the maintenance of autophagic-lysosomal function in 
neurons (Lu, Cai et al. 2009; Cai, Lu et al. 2010). 
It is very interesting that at least 20 proteins were reported to be SNAPIN interacting 
partner proteins demonstrating that SNAPIN might be an important scaffold protein 
participating in a number of cellular processes in various cell types. Other than 
SNARE proteins such as SNAP-25, SNAP-23 and synaptotagmin, SNAPIN was 
shown to be associated with the biogenesis of lysosome-related organelles complex-1 




melanosomes and platelet dense granules (Starcevic and Dell'Angelica 2004). The 
ryanodine receptor (RyR), a calcium channel located in the ER and one of the players 
in calcium-induced calcium influx and/or calcium release from internal stores, 
interacts with SNAPIN (Zissimopoulos, West et al. 2006). Cypin, a dendrite 
patterning protein, also interacts with SNAPIN and competes with tubulin for binding 
(Chen, Lucas et al. 2005). RGS7 (regulater of G-protein signaling 7) is a GTP se and 
binds to SNAPIN indicating a possible role of SNAPIN in G-protein signaling 
modulator (Hunt, Edris et al. 2003). SNAPIN can associate with the Exo70 subunit of 
the exocyst in regulating the trafficking and fusion of GLUT4 vesicles in adipocytes 
(Bao, Lopez et al. 2008). Other SNAPIN interactors include UT-A1 urea transporter 
(Mistry, Mallick et al. 2007), the transient receptor potential canonical fami y 
(TRPC6) (Suzuki, Morishima et al. 2007), dysbindin-1 and adenylyl cyclase VI (AC6) 
(Wang, Lin et al. 2009). 
Additional layers of SNAPIN regulation were discovered other than PKA 
phosphorylation. Casein kinase 1 delta (CK1δ) can phosphorylate SNAPIN and 
estrogen receptor-binding fragment-associated gene 9 (EBAG9) can bind to the 
domain of SNAPIN containing the phosphorylation site and regulate the function 
(Ruder, Reimer et al. 2005).  
1.5 Summary of dissertation work 
The long-range goal of this project was to better understand the biology of the human
parasite Trypanosoma cruzi, particularly focusing on the role of surface proteins in 
invasion and survival inside human host cells. T. cruzi is a kinetoplastid protozoan 




unusual ability gives T. cruzi access to the cytoplasm, which is critical for its survival 
and replication. One of the primary surface proteins in the infective form of T. cruzi, 
known as the Mucin-Associated Surface Protein (MASP), is encoded by a T. cruzi-
specific large multigenic family recently identified during the genome sequencing of 
T. cruzi CL Brener strain, the etiological agent of Chagas disease or American 
trypanosomiasis. This family consists of approximately 1,377 members that make up 
6% of all coding genes in the genome, suggesting that it has an important role in T. 
cruzi biology (El-Sayed, Myler et al. 2005; El-Sayed, Myler et al. 2005). The 
structure of MASPs is characterized by highly conserved amino- and carboxyl-
terminal domains encoding a signal peptide and GPI-anchor addition site respectively, 
and a hypervariable central region. Northern and Western blot analyses reveal that 
this family is predominantly expressed in the trypomastigote, the infective form of T. 
cruzi. Genome-scale microarray analysis indicates that steady-state MASP transcripts 
are highly expressed in the tissue-culture derived trypomastigote (TCT) form. In 
addition, in silico predictions suggest that MASP proteins are heavily glycosylated (7 
sites per sequence in average) and GPI anchored (Bartholomeu, Cerqueira et al. 2009). 
The role of the T. cruzi surface protein family MASP remained largely unknown.  
Based on previously reported results by our lab (El-Sayed), I hypothesized that 
members of the T. cruzi MASP protein family play a major role in the interaction of 
the parasite with the host cell. To test my hypothesis, I utilized molecular, genetic and 





The MASP family is predominantly expressed in T. cruzi trypomastigotes, the 
infective form of the parasite. In addition, members of this family are localized on the 
surface of the parasite by GPI-anchor (Bartholomeu, Cerqueira et al. 2009). Taken 
together, this evidence suggests that MASP could be involved in a host cell invasion 
process by interacting with human partner proteins.  The experiments documented in 
Chapter 2 identified interacting partner proteins of MASP proteins in the human 
proteome using yeast two-hybrid (Y2H) screen and confirm interactions by i  vivo 
co-affinity purification (co-AP) and in vitro pull-down assays. 
Preferential MASP expression in the infective stage (trypomastigote), as well as its 
cellular localization (Bartholomeu, Cerqueira et al. 2009), suggests a possible role of 
MASP in host cell invasion. Depleting endogenous MASP and overexpressing MASP 
in T. cruzi will help evaluate the role of MASP family and determine its biological 
relevance in the process of host cell invasion. Depletion or deletion of its human 
interacting partner protein would also allow us to investigate the function of putative 
MASP human interactors during T. cruzi invasion process. Therefore, my 
experiments documented in Chapter 3 were aimed at the investigation of a putative 
role of MASP human interacting partner proteins in the host cell invasion process 
using RNA interference (RNAi) technology, gene knockout primary cell lines, 
parasite invasion assay, co-localization studies and biochemical enzymatic tools. In 
addition, my experiments described in Chapter 4 were aimed at examining the 
putative function of MASP in the host cell invasion using MASP overexpression, 





Although more than a thousand genes in the T. cruzi genome encode MASP, we (The 
El-Sayed lab) have previously shown that only a small subset of this family is 
expressed in the trypomastigote cell population at a certain time point. Also the 
immunofluorescence data strongly suggests that MASP expressed is biased towards a 
subset of members (Bartholomeu, Cerqueira et al. 2009). To enter a wide variety of 
non-professional phagocytic cells, trypomastigotes seem to exploit heterogeneous 
glycoproteins such as mucin, trans-sialidase and GP85 (Buscaglia, Campo et al. 2006). 
However, the MASP expression pattern is still not clear. Our experiment documented 
in Chapter 5 studied the expression profile of masp genes and determined a subset of 
MASPs that correlates with host cell selection using the trypomastigote cDNA library 
and RNA-seq technology. 
1.6 Significance  
The masp family contains around 1,377 members and 771 intact genes, which consist 
of 6% of all coding genes in the T. cruzi genome implying its important role in T.
cruzi biology. MASP is expressed preferentially in the trypomastigote form (infect ve 
stage) of T. cruzi on the plasma membrane by GPI-anchor, thus suggesting an 
important role in host cell invasion. Elucidation of the role of MASP in T. cruzi as 
well as its human interacting partner protein will help us better understand the 
biology of T. cruzi and its interactions with the mammalian host, knowledge which 
can eventually improve the public health in the developing countries where research 






Chapter 2: Identification of interacting partner pr oteins of MASP 
proteins in the human proteome 
2.1 Objective of Study 
The MASP family is predominantly expressed in T. cruzi trypomastigotes, the 
infective forms of the parasite. In addition, at least some members of this family are 
localized on the surface of the parasite and attached through GPI-anchors. Taken 
together, this evidence suggests that MASP could be involved in a host cell invasion 
process by interacting with human partner proteins. We aimed to identify human 
interacting partner protein(s) of T. cruzi MASP proteins via yeast two-hybrid screens 
and other biochemical protein-protein interaction assays. 





Pretransformed normalized Matchmaker Human 
Universal cDNA Library 
638874 Clontech 
Glutathione-Uniflow Resin 635610 
Drop Out Supplement –Ade/–His/–Leu/–Trp 630428 
Drop-out Mix Synthetic Minus Leucine (SC-L) D9526 United States 
Biological Drop-out Mix Synthetic Minus Tryptophan (SC-T) D9530 
Drop-out Mix Synthetic Minus Leucine, Tryptophan 
(SC-LT) 
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Drop-out Mix Synthetic Minus Leucine, 
Tryptophan, Histidine (SC-LTH) 
D9539 
X-α-Gal B2175-05 

























Gateway® pDEST™27 11812-013 Invitrogen 
Gateway® pDEST™26 11809-019 
Gateway® pDEST™15 11802-014 
Gateway® pDEST™17 11803-012 
Gateway® pDONR™/Zeo 12535035 
Gateway® BP Clonase® II Enzyme mix 11789100 
Gateway® LR Clonase® II Enzyme mix 11791100 
E. coli BL21-AI strain C607003 
Pfx50™ DNA polymerase 12355012 
Ni-NTA Agarose resin R90101 
Lipofectamine™ 2000 11668-019 
mouse anti-GST monoclonal antibodies 136700 






Zymoprep™ Yeast Plasmid Miniprep II D2004 Zymo 
Research 
Biomek® FXP Laboratory Automation Workstation A31842 Beckman 
Coulter 
3-Amino-1,2,4-triazole (3AT) A8056 Sigma-
Aldrich mouse anti-c-Myc antibody M4439 
DNase I M0303 New England 
BioLabs 
Lysozyme 4403 Calbiochem® 
Dulbecco's Modification of Eagle's Medium 
(DMEM) 
15-013 Cellgro 
Protease Inhibitor Cocktail Set I 539131 Qiagen. 






Host cells and Yeast cells: HEK293T (Human Embryonic Kidney 293 T) cells were 
maintained in Dulbecco's Modification of Eagle's Medium (DMEM) supplemented 
with 10% heat inactivated Fetal Bovine Serum (FBS) at 37ºC with 5% CO2. 
Saccharomyces cerevisiae strains AH109 and Y187 were cultured on YPAD agar 
plate at 30ºC in a humid incubator. 
 Protein-protein interaction screens, generating bait and prey plasmids: Primers 
(See Appendix B.1 for sequence) were designed to anneal to the firs and last 20 nt of 
the coding sequence (CDS) in T. cruzi MASP1 
(Tc00.1047053504587.30/6336.m00003) and MASP4 
(Tc00.1047053509979.350/8263.t00035) Open Reading Frames (ORFs). Stop codons 
were excluded from reverse primer sequences to allow downstream cloning into 
vectors with C-terminal fusion tags. Primers also included attB overhang sequences 
providing the recombination sites for Gateway® universal cloning (Invitrogen). T. 
cruzi MASP genes were amplified by the polymerase chain reaction using the Pfx50™ 
DNA polymerase according to the manufacturer’s instructions. Thermal amplification 
consisted of an initial denaturation step at 94ºC for 2 minutes, followed by 25 cycles 
of denaturation at 94ºC for 20 seconds, annealing at 60ºC for 45 seconds (decreased 
by 0.2ºC per cycle), and extension at 68ºC for 90 seconds (increased by 3 seconds per 
cycle), followed by another 10 cycles of denaturation at 94ºC for 15 seconds, 
annealing at 55ºC for 45 seconds and extension at 68ºC for 150 seconds, with a final 
extension step of 68ºC for 10 minutes. Amplicons were cloned into the pDONR™/Zeo 




and M13 Reverse primers. Inserts were also shuttled in parallel to the GAL4 DNA 
Binding Domain (GAL4 DBD) bait vector, pGBKT7g. 
Two human libraries served as prey in independent screens: 1) Pretransformed 
normalized Matchmaker Human Universal cDNA Library and 2) hORFeome 3.1 (a 
12,000 human ORF collection cloned into a Gateway recombinational entry vector). 
Yeast transfection, mating and screening: Saccharomyces cerevisiae strains AH109 
(MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4∆, gal80∆, LYS2::GAL1UAS-
GAL1TATA-HIS3, GAL2UAS-GAL2TATA-ADE2, URA3::MEL1UAS-MEL1TATA-lacZ, MEL1) 
and Y187 (MATα, ura3-52, his3-200, ade2-101, trp1-901, leu2-3, 112, gal4∆, met–, 
gal80∆, MEL1, URA3::GAL1UAS -GAL1TATA-lacZ) were used and transfected with bait 
and prey vectors, respectively, according to the ProQuest™ Two-Hybrid System 
transfection protocol (Invitrogen).  
Two MASP test baits, pGBKT7g-MASP1 & pGBKT7g-MASP4, and control bait, 
pGBKT7-p53, were screened against the pretransformed normalized Matchmaker 
Human Universal cDNA Library according to the manufacturer’s instructions. Briefly, 
bait plasmids were transfected into AH109 (MATa strain) and the transfectants were 
selected on SC-Trp (SC-T) plates. One fresh and large bait colony was inoculated into 
50 mL of SC-T liquid medium and incubated at 30ºC with shaking (250 rpm) until 
OD600 reached 0.8. The cells were harvested at 1,000x g for 5 minutes and 
resuspended in 5 mL SC-T. The 5 mL bait cells were combined with 1 mL of Y187  
(MATα strain) pretransformed cDNA library and added to 45 mL of 2X YPAD liquid 
medium. Combined bait and prey cells were incubated at 30ºC for 20~24 hours with 




resuspended in 10 mL 0.5X YPAD. The resuspended diploid cultures were spread 
onto 150 mm SC/-Ade/-His/-Leu/-Trp/X-α-Gal (Quadruple Drop-Out [QDO]+X-α
Gal) agar plates and incubated for a week at 30ºC. Positive blue colonies were picked 
and further cultured in SC/-Leu/-Trp (SC-LT). Positive bait and prey lasmids were 
isolated by Zymoprep™ Yeast Plasmid Miniprep II and isolated preylasmids were 
identified by sequencing the insert using T7 primer (5’- 
TAATACGACTCACTATAGGG-3’). Preys identified as TP53 positive interactors 
were confirmed against known TP53 interactors in the IntAct database 
(http://www.ebi.ac.uk/intact/).  
For screens against the human ORFeome, pools of 128 AD fusion proteins were 
shuttled from hORFeome 3.1 into the GAL4 AD prey vector pGADT7g, transfected 
into the Y187 yeast strains, selected on SC-Leu (SC-L) media and re-arrayed into a 
96-well format. Mating of the yeast strains was carried out in Nunc™ OmniTrays 
containing solid media and performed on a Biomek® FXp laboratory automation 
workstation equipped with a 96-pin tool. Baits (AH109 yeast strain harboring 
pGBKT7g-MASP1 or pGBKT7g-MASP4), and preys were transferred onto selective 
media (SC-T and SC-L, respectively) and grown for 2 days at 30ºC.  Mating was 
carried out by transferring bait and prey cells onto the same spot on the OmniTray 
containing complete media (YPAD), followed by a 16-hour incubation at 30ºC. 
Following mating, colonies were transferred to SC-Leu-Trp (SC-LT) media to select 
for diploid cells containing both bait and prey plasmids. Positive and negativ  
controls for protein interaction were added to those plates. Diploid cells transfected 




for auto-activation of the HIS3 reporter gene. Colonies were cultured on multiple 
plates containing SC-Leu-Trp-His (SC-LTH) and distinct concentrations of 3-Amino-
1,2,4-Triazole (3AT) in order to determine 3AT sensitivity and the optimal 3AT 
concentration for efficient HIS3 inhibition. For each of the baits, the concentration of 
3AT, which provided minimal growth, comparable to a negative control, was later 
used to suppress auto-activation. Bait/prey coding genes clones in the 
pGBKT7g/pGADT7g vector system were evaluated with 3AT concentrations of in 0, 
2.5, 5.0, 7.5, 10.0, 12.5, 15.0 and 25.0 mM. Diploid cells containing bait and prey 
vectors were transferred to SC-LTH media lacking adenine and complemented with 
40 µg/ml of X-α-Gal and appropriate 3AT concentration, enabling the evaluation of 3 
different gene reporters at once. Cells were incubated at 30°C and inspected over a 
period of one week. Diploid cells that exhibited the phenotype associated with the 
expression of three gene reporters were assigned as positives.  
In vivo co-affinity purification (co-AP) assays: Commercially available full-length 
human Snapin ORFwas shuttled from pDONR™/Zeo into the mammalian expression 
vector pDEST™27 containing an N-terminal glutathione S transferase (GST) tag. 
MASP1 and MASP4 fragments lacking the signal peptide and GPI anchor addition 
site (described in Figure 2-8) were cloned into pDONR™/Zeo and recombined into 
pDEST™26 containing an N-terminal 6xHis tag. Empty pDEST™27 served as a 
negative control. The interacting protein pairs of GST-bait (GST alone, GST-
sMASP1 and GST-sMASP4) and 6xHIS-prey (6xHIS-Snapin) were co-transfected 
into HEK293T using Lipofectamine™ 2000 according to the manufacturer’s 




30 minutes with lysis buffer containing 1% NP-40, 50 mM Tris-HCl pH 7.5, 150 mM 
NaCl, 1 mM EDTA, 1 mM Phenylmethylsulfonyl fluoride (PMSF) and a cocktail of 
additional protease inhibitors. Cell lysates were cleared by centrifugaion at 15,000x g 
for 15 minutes at 4°C, and soluble protein complexes were purified using 
Glutathione-Uniflow Resin. Resin-protein complexes were washed extensively with 
cell lysis buffer and analyzed by SDS-PAGE. GST- and 6xHis-tagged proteins were 
detected by standard immunoblotting techniques using mouse anti-GST and anti-His 
monoclonal antibodies. 
In vitro Pull-down assays: Full-length T. cruzi MASP1 and MASP4 ORFs and 
snapin ORF were cloned into bacterial expression vectors pDEST™15 harboring an 
N-terminal GST tag and pDEST™17 harboring a C-terminal 6xHis tag, respectively. 
pGEX-5 vector was used to express the GST protein as a negative control. The 
expression vectors were transformed into E. coli BL21-AI strain according to the 
manufacturer’s instructions. Transformants were cultured for 3 hours at 37ºC and 225 
rpm until the logarithmic phase and the recombinant protein expression was induced 
by addition of L-arabinose to the final of 0.2%. Cells were harvested by 
centrifugation 4 hours after induction and lysed in lysis buffer (50 mM Potassium 
Phosphate, pH 7.8, 400 mM NaCl, 100 mM KCl, 10% glycerol, 0.5% Triton X-100, 
10 mM Imidazol) supplemented with DNase I and lysozyme. Cell lysates were 
cleared by centrifugation and each supernatant fraction was combined with another 
interaction pair. After 1-hour incubation at 4ºC, interacting protein complexes wer 





2.3 Results and Discussion 
2.3.1 Yeast two-hybrid screening identified human SNAPIN as a putative 
MASP interacting protein 
To identify the putative human interacting partner proteins of T. cruzi MASP protein 
family, two distinct yeast two-hybrid prey libraries were employed: the normalized 
human cDNA library and the full-length open reading frame (ORF) collection 
(human ORFeome corresponding to ~12,000 protein coding genes) (Rual, 
Venkatesan et al. 2005; Lamesch, Li et al. 2007). To reduce the abundant transcripts, 
normalization of a mixture of poly-A RNAs from a collection of male and femal 
tissues was performed using kamchatka crab duplex-specific nuclease (DSN) and the 
normalized human cDNA library was available as pretransformed in yeast Y187 
(MATα) strain. MASP1 was initially chosen as bait among 771 MASP family 
members because the high expression of this member was reported in our previous T. 
cruzi trypomastigote cDNA library screening study (Bartholomeu, Cerqueira et al. 
2009) (Figure 2-2). MASP4 was selected as an additional representative of the family 
due to its different size (estimated molecular weight of MASP1 is 16 kDa and 
MASP4 is 32kDa) and a different central domain composition from MASP1 (Figure 
2-4) although it still retains the conserved N-terminal (amino acids 1-28 in both 
MASPs) and C-terminal domains (amino acids 126-177 in MASP1 and 270-321 in 
MASP4) that are one of the characteristics of MASP multigenic family (Figure 2-3). 
The two MASP ORFs were amplified directly from the T. cruzi CL Brener genome 
with a pairs of gene-specific primers containing attB sequence overhangs for the 




Figure 2-1. Y2H screen pipeline and validation of PPIs in two heterologous 
systems. (A) Amplification: 
(Tc00.1047053504587.30/6336.m00003) and 
(Tc00.1047053509979.350/8263.t00035), were amplified from 
DNA using gene-specific primers preceded by 
Gateway® cloning system. (B) Entry clonin
the Gateway® pDONR™/Zeo vector, which contains 
48 
masp genes, masp1 
masp4 
T. cruzi genomic 
attB recombination site for the 
g: masp amplicons were recombined into 





reaction. (C) Destination cloning: masp1 and masp4 were then shuttled to the 
pGBKT7g vector (bait) by LR reaction. Human ORFs in the entry vectors were 
pooled and recombined into pGADT7g (prey) as a batch. (D) Transfection: Bait and 
prey clones were transfected into yeast cells, AH105 (MATa) and Y187 (MATα), 
respectively and plated on media lacking Tryptophan or Leucine for the selection. 
Prey clones containing normalized human universal cDNAs were provided as a pre-
transformed library (Clontech) (left) and pools of 128 ORFs from hORFeome 3.1 
were transfected into Y187 (MATα) yeast strain and selected on media lacking 
Leucine in a 96-well format (right). (E) Mating: Transfected yeast h ploid cells were 
mated for 24 hrs and plated on the selective media lacking Tryptophan, Leucine, 
Adenine, and Histidine but supplemented with X-α-gal for the screen (left). For 
hORFeome library, mating of the yeast strains were perfomed on a robot using a 96-
pin. Bait and Prey were spotted onto selective media lacking Tryptophan and Leucine 
and grown for two days and subsequently transferred to the selective media lacking 
Tryptophan, Leucine, Adenine, and Histidine but supplemented with X-α-gal for the 
screen (right) (F) co-AP: Interactions identified from the previous Y2H screen were 
validated by a co-Affinity Purification (co-AP) method in HEK293T cells using 
pDEST™27 (bait) and pDEST™26 (prey) vectors. (G) Pull-down: Parallel evaluation 
of the interaction was conducted in E. coli BL21-AI strain using pDEST™15 (bait) 




Figure 2-2. masp expression profiling in trypomastigote population. A 
CL Brener strain trypomastigote cDNA li
region and 15,000 phages were screened generating around 600 positive clones (~ 
4%). 52 cDNA clones were sequenced and BLASTed against 
analysis revealed 20 clones of full







brary was probed with 3’ UTR conserved 
T. cruzi genome. 









Figure 2-3. The two MASP baits used in Y2H screen 
MASP proteins. Boxes with bold line represent N
sequences with 96.4% and 90.4% similarity respectivly. SP: signal peptide, GPI: 
GPI-anchor addition site. (B) Immunoblot analysis demonstrates the expression of c
Myc-tagged MASP1 and MASP4 recombinant proteins in yeast AH109 cells. 
Untransfected AH109 cell lysates (lane 1), pGBKT7g
(lane 2), pGBKT7g-MASP1
MASP4-transfected AH109 cell lysates (lane 4) were probed with anti
antibodies. (* Lower mobility (i.e. higher molecular weights) for MASP1 and 





(A) A schematic map of 
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Figure 2-4. Protein sequence comparison between MASP1 and MASP4. 
and MASP4 amino acid sequences were analyzed by EMBOSS Needle program to 
find the optimal global sequence alignment. Highly conserved N



















Figure 2-5. Putative human interacting partner proteins that bind to both 
MASP1 and MASP4. (A) Blue yeast colony growth on the selective media 
representing positive protein
screening analysis revealed several interactors of MASP including human SNAP
associated protein (SNAPIN) and COP9 signalosome subunit 5 variant (CSN5). 
Heterogeneous nuclear ribocleoprotein H3 (HNRNPH3) turned 













-protein interactions. (B) Yeast 2-hybrid (Y2H) 








Subsequently, they were gateway-cloned into pGBKT7g yeast two-hybrid (Y2H) 
expression vector that was engineered by Dr. Peter Uetz to generate pGBKT7-masp 
plasmids (bait) (Rajagopala, Casjens et al. 2011). Following the transfection of 
AH109 (MATa) yeast strain with each bait plasmid, the expression of yeast 
recombinant proteins (DBD-MASP-c-Myc) in fusion to Gal-4 DNA binding domain 
(DBD) was validated by the standard immunoblotting analysis using anti-c-Myc 
antibodies (Figure 2-3 B). Detection of bigger recombinant MASP1 and MASP4 
proteins expression than the expected sizes (26 kDa and 42kDa theoretically) may 
represent a different post-translational modification (PTM) in the heterologous 
system especially a heavy glycosylation decoration event in yeast is well-documented 
elsewhere (Figure 2-3 B) (Conde, Cueva et al. 2004). The suppression of transcription 
auto-activation of baits was evaluated with the various concentration (0 ~ 100mM) of 
3-Amino-1,2,4-triazole (3-AT) in the selective media and achieved by applying 2.5 
mM 3-AT for both MASP baits. Thereafter the selective media plates were 
supplemented with 2.5 mM 3-AT to prevent the leaky expression of bait unless noted 
otherwise. The initial screening against the pretransformed normalized Matchmaker 
Human Universal cDNA Library, Y187 (MATα) yeast strain containing normalized 
human cDNAs in fusion to Gal-4 activation domain (AD) in pGADT7-rec Y2H 
expression vector, yielded 62 and 86 putative protein-protein interactions (PPIs) for 
baits, MASP1 and MASP4, respectively (Table 2-1). The plasmids from each yeast 
colony were extracted using Zymoprep yeast plasmid miniprep kit and the prey 
plasmid harboring an Ampicillin resistant gene was separated from the bait plasmid 




Table 2-1. The list of putative human interactors of MASP. 
individual cDNA plasmids retrieved from the yeast 2
MASP1 or (B) MASP4 as bait were sequenced and search d against the NCBI non
redundant (nr) database. The BLAST searches showed several interesting putative 
interactors of MASP including human SNAP
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-hybrid screening using (A) 







The insert of the isolated prey plasmids was subsequently sequenced and 37% (24/62) 
and 49% (42/86) of the sequenced cDNA inserts from each screening were identified 
as SNAP-associated protein (SNAPIN), the protein implicated to function in a 
calcium-dependent exocytosis in neurons by binding to SNAP25 (Ilardi, Mochida et 
al. 1999; Buxton, Zhang et al. 2003; Tian, Wu et al. 2005). COP9 signalosome 
subunit 5 variant protein (CSN5), a protein shown to regulate multiple signalling 
pathways (Kim, Lee et al. 2004; Yoshida, Yoneda-Kato et al. 2010), was also found 
to be a putative interactor with both MASP proteins (Figure 2-5). Several nuclear 
proteins including heterogeneous nuclear ribonucleoprotein H3 and ring finger 
protein 2 turned out to be non-specific binding based on a pairwise Y2H assay. 
Presumably they directly interact with the DNA binding domain (DBD) sequence 
even in the absence of protein-protein interaction. We identified a few additional 
putative interactors. Although they looked interesting, we did not pursue them in this 
study because they were only detected in one of two Y2H screens thus it is likely to 
represent a non-specific binding. For instance, killer cell lectin-like rec ptor and 
layilin containing a lectin domain were identified as MASP1 interactors in our Y2H 
screens, showing the MASP recombinant protein expressed in yeast is very likely 
glycosylated. Another interactor, contactin-associated protein is one of cell adh sion 
molecules and located on the membrane and this suggests a biologically relevant 
interaction and the putative function of MASP protein in cell attachment but 
contactin-associated protein was only found in Y2H screening when MASP1 protein 
was used as bait. Also the interaction with calcium modulating ligand (CAMLG) 




Figure 2-6. Protein-protein interaction from 
pairwise assays. Mated bait and prey yeast strains were either streaked manually or 
pinned in quadruplicate using a 96
dropout media lacking Tryptophan, 
supplemented with X-α-gal
MASP4 and SNAPIN (bottom right, A and B) are indicat ng positive protein
interactions. Human TP53 protein (pGBKT
(pGADT7-SV40 large T-antigen: prey) were used as a positive control for Y2H 
interaction (upper left, A and B) and an empty pGBKT7g vector and pGADT7g






Y2H screens was confirmed in 
-pin tool on a Biomek® FXp onto the quadruple 
Leucine, Adenine, and Histidine but 
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MASP also pulled out the protein complex that consists of HLA-B associated 
transcript 3 (BAT3), CAMLG and immediate early response 3 (IER3) that are 
implicated in the regulation of apoptosis (Table 2-1). These putative interactors were 
excluded primarily because they were not detected from both screenings and a couple 
of them were nuclear such as BAT3 and IER3 so these interactions do not likely 
occur in vivo. Between SNAPIN and CSN5, we decided to focus on SNAPIN for the 
downstream analyses rather than CSN5 since CSN5 is nuclear/cytosolic (Tomoda, 
Kubota et al. 2002) whereas SNAPIN is membrane-bound (Buxton, Zhang et al. 
2003), thus more biologically relevant for our work. Bait and prey plasmids rescued 
from the positive yeast colony were again used for a Y2H assay in a pair-wise manner 
to confirm the direct interaction between MASP and SNAPIN. This excludes the 
possibility of indirect interaction, i.e. the interaction within the same complex or false 
positive due to yeast diploid cells harboring multiple prey plasmids. Human TP53 and 
SV40 large T-antigen were used to validate the Y2H system and the empty Y2H 
expression vector (pGBKT7g) and SNAPIN were used as a negative control and 
demonstrated that SNAPIN does not bind non-specifically to DBD sequence (Figure 
2-6 A and B top). Both MASP1 and MASP4 showed strong interactions with 
SNAPIN as indicated by blue yeast diploid cell growth on the selective media when 
they were streaked manually (Figure 2-6 A bottom) or they were pinned in 
quadruplicate by Biomek® FXp. 
Next, we performed the screening against the human ORFeome (hORFeome 3.1) in 
an array format. The prey library was prepared by transfecting the Y187 (MATα) 




the hORFeome collection fused to Gal-4 AD in the pGADT7g Y2H expression vector, 
and spotting the 94 mini-libraries on Nunc™ OmniTrays in a 96-well format. The 
mating of bait and prey and the transfer of the mated diploid cells onto the selective 
media were conducted on a Biomek® FXp laboratory automation workstation 
equipped with a 96-pin tool. As expected, we could detect the PPI signal from a 
colony from a pool containing SNAPIN. This consistency in screen result using two 
different Y2H platforms adds confidence and reliability to the interaction between 
both MASP proteins and SNAPIN as well as the sensitivity of Y2H screening. The 
development of a high-throughput Y2H system will facilitate the emergence of the 
host-pathogen interactome (infectome) field by taking advantage of our automated 
workflow. 
2.3.2 MASP and human SNAPIN protein interaction was confirmed using 
other heterologous systems 
In order to rule out that the interaction is not the result of the yeast two-hybrid system, 
we validated the physical interaction between MASP and SNAPIN using additional 
approaches. We conducted two additional PPI assays in heterologous biological 
systems. 6xHis-SNAPIN (bait) and the GST alone and GST-MASPs (prey) were 
independently transformed and expressed in E. coli overexpression strain, BL21-AI. 
An equimolar amount of total cell lysates was combined in a pair of bait and prey and 
incubated for 1 hour at 4ºC followed by the purification of protein complexes using 
Ni-NTA agarose beads. Recovered protein complexes were subjected to standard 
immunoblotting analysis. The results clearly demonstrated 6xHis-tagged recombinant 
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and captured by Ni-NTA resin as expected (Figure 2-7 A). Also GST and GST-
tagged MASP proteins were expressed and present in soluble fraction but only GST-
tagged MASP proteins were purified along with SNAPIN in a complex by Ni-NTA 
resin (Figure 2-7 B). This data indicates that both MASP1 and MASP4, but not GST 
protein alone, are interacting with SNAPIN in a bacterial system (Figure 2-7) even in 
the absence of post-translational modification such as N-linked or O-linked 
glycosylations previously predicted on MASP proteins in ilico (Bartholomeu, 
Cerqueira et al. 2009). This rules out the possibility of non-specific binding due to the 
putative sticky nature of the MASP glycoprotein.  
We next performed in vivo co-affinity purification (co-AP) assay to test the 
interaction between MASP and SNAPIN in a mammalian system, representing 
another heterologous system in order to add confidence on our PPI data. HEK293T 
cells were transiently co-transfected with a pair of GST-bait (GST alone and GST-
sMASPs) and 6xHis-prey (6xHis-SNAPIN) constructs. Fusion proteins were 
overexpressed for 48 hours and the interacting protein complexes in the cell lysat s
were purified using glutathione sepharose (GSH) resin. MASP proteins, despite their 
soluble GST tag, were mostly insoluble when overexpressed in a mammalian system. 
This is likely due to the hydrophobic signal peptide and GPI-anchor regions at their 
N- and C-terminal domains, respectively (Figure 2-8) (Bartholomeu, Cerqueira et al. 
2009; De Pablos, Gonzalez et al. 2011). We removed these hydrophobic sequences 
from the full-length MASP ORFs in order to improve the solubility of the 
recombinant proteins expressed in the mammalian cells in this experiment with the 




Figure 2-8. Validation of MASP
Purification. GST protein alone and GST
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peptide and GPI addition site domains predicted by in silico analysis are eventually 
cleaved out during the post transcriptional processing in T. cruzi. GST alone was used 
as a negative control and showed that GST protein alone does not interact with either 
MASP1 fragment or MASP4 fragment (Figure 2-8 A-C, left panel). GST-tagged 
SNAPIN was expressed in soluble and purified by GSH resin (Figure 2-8 A, right 
panel). The expression of soluble 6xHis-tagged MASP1 fragment was still poor in 
spite of our attempt to cleave the hydrophobic region and absent in the protein 
complex when purified with GSH resin (Figure 2-8 B, right panel). Soluble 6xHis-
tagged MASP4 fragment expression in HEK293T cells was better than MASP1 
fragment and detected faintly in the protein complex along with GST-tagged 
SNAPIN (Figure 2-8 C, right panel). Our results show SNAPIN is interacting albeit 
weakly with the MASP4 fragment (sMASP4) but not with the MASP1 fragment 
(sMASP1) in the mammalian system (Figure 2-8). It is possible that the interaction 
with MASP1 was not detectable due to low expression level or persistent insolubility 
of the MASP1 fragment.  
2.4 Conclusions and significance 
In this section of the work, we have established a robust high-throughput platform for 
screening protein-protein interactions between trypanosomatid and human 
proteins.and used the system to identify for the first time the human interacting 
partner protein of T. cruzi MASP proteins. Although we have tested only two out of 
771 members, human SNAPIN turned out to be physically interacting with both 
MASP1 and MASP4 despite the striking differences in hypervariable domains. It is 




responsible for this interaction. It will be interesting to study the 3D structures of 
MASP family and determine if they could share any common structure overcoming 
the sequence variation like variant surface glycoprotein (VSG) family in T. brucei. 
VSG family consists of 806 members in T. brucei genome and antigenic variation is 
achieved by switching a member of glycoprotein in the bloodstream of the host 
(Berriman, Ghedin et al. 2005). Even though the primary sequence of VSG N-
terminal domain show low similarity, the crystallized 3D structure revealed strikingly 
high similarity in N-terminal domain demonstrating VSG family may have a common 
N-terminal structure (de Carvalho, da Silva et al. 2002). Hence, it cannot be ruled out 
that the central hypervariable region of MASP may have a common structure playing 
a major role in the protein-protein interaction with SNAPIN. Yeast two-hybrid offers 
a great advantage as a high throughput screen method for the  rapid identification of 
protein-protein interaction between host and pathogens. Potentially yeast two-hybrid 
screening method, combined with next generation sequencing technology will allow 
massive PPI identification that will be beneficial in speed and quantity to unexplor d 
host-pathogen interactome or infectome. Also the confirmation by other heterologous 
systems will provide confidence in the PPI identified from Y2H screen. 
The MASP and SNAPIN interaction identified from Y2H screens and confirmed in 
two different heterologous systems was very interesting since T. ruzi was known to 
exploit the host calcium-regulated lysosome pathway for cell invasion (Schenkman, 
Robbins et al. 1991; Tardieux, Webster et al. 1992). T. cruzi causes a transient 
intracellular calcium increase in the host cell that initiates the recruitment and fusion 




complex protein actions and SNAPIN was one of them (Ilardi, Mochida et al. 1999). 
Also SNAPIN was implicated in calcium-dependent exocytosis in neurons (Tian, Wu 
et al. 2005). In Chapter 3, we tested if the interaction between MASP and SNAPIN 
has a biological relevance in the parasite invasion process using several functional 
assays. 




Chapter 3: The putative role of SNAPIN in host cell invasion  
3.1 Objective of Study 
Preferential MASP expression in the infective stage of T. cruzi as well as its cellular 
localization, suggest a possible role of MASP in the host cell invasion process. As our 
attempt to raise antibodies against MASP has been difficult (Bartholomeu, Cerqueira 
et al. 2009) and the range of genetic tools for the functional analysis of T. cruzi genes, 
multigenic gene family in particular, was limited, we aimed to characte ize the 
putative function of MASP by elucidating the role of SNAPIN, a human interacting 
partner protein of MASP, via several genetic, molecular, biochemical approaches 
available for human and mouse cell lines.  
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Ionomycin I9657 Sigma-Aldrich 
p-nitrophenyl-N-acetyl-β-D-glucosaminide N9376 Invitrogen 
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SNAPIN siRNA oligomers HSS118960, 
HSS118961, 
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Lipofectamine™ 2000 Transfection Reagent 11668-019 
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Roche 
Rabbit anti-SNAPIN polyclonal antibodies 148 002 Synaptic 
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Mouse anti-SNAPIN monoclonal antibodies 75-045 NeuroMab 
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Scientific 
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15-013-CV Cellgro 
Heat-inactivated Fetal Bovine Serum (FBS) 100-106 Gemini Bio-
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Rab5-YFP vector  
Rab9-YFP vector  
Rab11-YFP vector  
3.2.2 Methods 
Host cells and Parasites: HeLa cells (CCL-2.1), LLC-MK2 (Rhesus Monkey Kidney 
Epithelial) cells and NRK (Normal Rat Kidney) cells were maintained in DMEM 
supplemented with 10% heat-inactivated FBS at 37ºC with 5% CO2. SNAPIN Wild-
Type (WT) and Knock-Out (KO) Mouse Embryonic Fibroblast (MEF) cells at 
passage 8 were cultured in DMEM supplemented with 10% FBS at 37ºC and 5% CO2. 
Trypanosoma cruzi epimastigotes (CL Brener and Y strains) were maintained in 
Liver Infusion Tryptose (LIT) medium (Villar, Jimenez-Yuste et al. 2002) with 10% 




purified from 10-day old LIT culture by ion-exchange chromatography (DEAE 
cellulose) and Tissue-Culture derived Trypomastigotes (TCTs) were obtained from 
infected LLC-MK2 cells.  
Mouse SNAPIN RNAi assays: HeLa cells (2x105) in DMEM with 10% heat-
inactivated FBS were plated on glass coverslips in a 6-well plate 24 hours prior to 
transfection. HeLa cells were transfected with 180 pmoles of a pool of three SNAPIN 
siRNA oligomers or control siRNA oligomer using Lipofectamine™ 2000 according 
to the manufacturer’s instruction. Forty-eight hours following transfection, the 
efficiency of SNAPIN depletion was assessed using standard immunoblotting 
techniques using mouse anti-SNAPIN monoclonal antibodies and 
Immunofluorescence assay (IFA) using mouse anti-SNAPIN monoclonal antibodies 
and Alexa Fluor 488–labeled secondary antibodies. Images were acquired by Zeiss 
epifluorescence microscope (Observer Z1). 
Parasite invasion assays: Y strain T. cruzi TCTs (4x107) were incubated with 
transfected HeLa cells (MOI=200) for 20 minutes and washed extensively with PBS. 
Infected HeLa cells were immediately fixed with Bouin’s solution (71.4% saturated 
picric acid, 23.8% formaldehyde, and 4.8% acetic acid) for 20 minutes, followed by 
Giemsa staining overnight at room temperature. A series of dehydrations in a gradient 
solution of acetone, 9:1, 7:3, 3:7 acetone/xylene, and xylene enabled the 
differentiation of intracellular and extracellular parasites (Fernandes, Cortez et al. 
2011). Intracellular TCTs show a halo surrounding the parasite due to the 
parasitophorous vacuole whereas TCTs outside the cell do not. The number of 




averaged. For MEF cells, 4x105 cells were plated in a 6-well plate 24 hours prior to 
infection and then exposed to 4x107 TCTs of T. cruzi Y strain (MOI=100) for 20 
minutes and further processed as described above. 
SNAPIN subcellular localization: HeLa cells (2x105) were plated on glass coverslips 
in a 6-well plate 24 hours before experiments and transfected with the Rab9-YFP 
plasmid using FuGENE® HD. HeLa cells were infected 48 hours after transfection 
with 1x107 T. cruzi Y strain metacyclic trypomastigotes (MOI=50) for 1 hour and 
subjected to IFA as described below. For adenovirus transduction, HeLa cells were 
transduced 24 hours prior to the experiment by adding adenovirus encoding LAMP1-
RFP at a 1:10 MOI to the culture media. 
Immunofluorescence: Cells were fixed with fresh 4% paraformaldehyde (PFA) 
diluted in PBS for 10 minutes at room temperature, washed with PBS 3 times, and 
quenched with 15 mM NH4Cl. The samples were then blocked with 2% BSA-
containing PBS for 1 hour at room temperature. Cells on the glass coverslip were 
permeabilized with 0.1% Saponin for 10 minutes if necessary. The samples were 
incubated with mouse anti-SNAPIN monoclonal antibodies for 1 hour followed by 
anti-mouse Alexa Fluor 594 secondary antibody incubation. Images were acquired 
using the confocal microscope (Leica SP5 X) in the imaging core facility (University 
of Maryland, College Park). For MEF cell IFAs, both SNAPIN WT and KO MEF 
cells were stained with mouse anti-LAMP1 (H4A3 clone) antibodies for 1 hour 
followed by anti-mouse Alexa Fluor 594 secondary antibodies.  
Host lysosome recruitment quantification: MEF cells (6x105) were seeded onto 




with 6x107 T. cruzi Y strain TCTs expressing GFP (MOI=100) for 20 minutes and 
washed extensively with PBS in order to synchronize the entry of the parasite. 
Washed MEF cells were fixed either immediately, or following a 20 minute- or 40 
minute- additional incubation and processed with for IFA. Acquired images from 
each time point were analyzed with Leica LAS AF Lite software (version 2.4.1) for 
the host lysosome pixel intensity quantification surrounding the invading parasite. 
Lysosomal enzyme release assay: The release of two different lysosomal enzymes, 
β-hexosaminidase and β-galactosidase, was measured using a fluorometric method. 
MEF (6x105) cells were plated 24 hours prior to the experiment and treated with or 
without 10 µM ionomycin. Secreted β-hexosaminidase and β-galactosidase present in 
the supernatant and total cell lysates were incubated in sodium citrate-phosphate 
buffer, pH 4.5 containing 6 mM p-nitrophenyl-N-acetyl-β-D-glucosaminide and in 
acetate buffer pH 5.0 containing 5 mM 4-methylumbelliferyl-β-D-galactoside 
respectively for 20 minutes at 37°C. The reaction was terminated by the addition of 
stop buffer (2M Na2CO3, 1.1M glycine). Absorbance at 405 nm was read in an 
enzyme-linked immunosorbent assay (ELISA) reader and the results were 
normalized as the percentage of enzyme activities released into the supernatant over 
the total cell lysates. 
Calcium-dependent SNAPIN exposure assay: NRK (4x105) cells were plated on 
glass coverslips in a 6-well plate 24 hours before experiments. The cells were 
incubated for 10 minutes in the presence or absence of 10 µM ionomycin in the 
buffer with or without 20 mM calcium and fixed with 4% fresh PFA for 10 minutes. 




permeabilized for the detection of exposed SNAPIN. The glass coverslips were 
incubated further with rabbit anti-SNAPIN polyclonal antibodies followed by anti-
rabbit Alexa Fluor 594 secondary antibodies and examined by the confocal 
microscope (Leica SP5 X) in the imaging core facility (University of Maryland, 
College Park)..  
3.3 Results and Discussion 
3.3.1 Depletion or deletion of SNAPIN reduces cells invasion of T. cruzi 
Since the deletion of 1,377 copies of a MASP family in T. cruzi is not feasible and the 
RNA interference (RNAi) pathway is absent in T. cruzi (DaRocha, Otsu et al. 2004; 
El-Sayed, Myler et al. 2005; El-Sayed, Myler et al. 2005), we decided to deplete 
SNAPIN in the HeLa cells with three human SNAPIN small interfering RNA (siRNA) 
oligomers and perform a T. cruzi invasion assay to investigate the possible role of 
human SNAPIN protein in the parasite invasion process. Recently RNAi has been 
used extensively as a great reverse genetic tool to identify host proteins that mig t be 
crucial for the T. cruzi invasion and intracellular survival from a single gene (Nde, 
Simmons et al. 2006; Simmons, Nde et al. 2006; Claser, Curcio et al. 2008) to the 
genome-wide level (Genovesio, Giardini et al. 2011). Unlike T. brucei where the full 
RNAi machinery is present in the genome, genome sequencing of T. cruzi revealed 
that T. cruzi lacks two components, AGO1 and dicer, therefore RNAi is inactive. The 
majority of Leishmania spp. are also RNAi-incompatible but Leishmania brazilnensis 
was shown to retain the RNAi machinery recently (Lopez-Molinero, Villarea  et al. 




Figure 3-1. Three targets of snapin siRNA oligmers. 
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targets towards C-terminal region of snapin based on the most up-to-date 
bioinformatics and known information about miRNA seed region (Figure 3-1). The 
efficiency of gene silencing was validated with standard immunoblotting and 
immunofluorescence analyses (Figure 3-2 B-D). A pool of three SNAPIN siRNA 
oligomers was used for the following experiment. The three siRNAs combined 
proved to  be the most effective in gene expression down-regulation according to the 
immunoblotting analysis result (Figure 3-2 B). HeLa cells transfected with either a 
pool of SNAPIN siRNA oligomers or the scrambled control siRNA oligomers 
designed to not target any genes in the human genome 24 hours prior to the invasion 
assay were exposed to T. cruzi Y strain trypomastigotes (MOI=250) for 20 minutes to 
evaluate the initial infection of T. cruzi. Following exposure, infected HeLa cells 
were fixed with Bouin’s fixative and stained with Giemsa solution. The cells were
dehydrated by a gradient of acetone/xylene solution that enabled us to distinguish the 
intracellular parasites and the extracellular parasites due to the presence of the halo. 
Once T. cruzi invades the cell, it resides within the parasitophorous vacuole. During 
the dehydration process, the parasite inside the parasitophorous vacuole displays the 
halo caused by the luminal space between the parasite surface and the vacuole 
membrane (Figure 3-2 E). The number of intracellular parasites per 200 HeLa cells 
were counted and compared to each other. SNAPIN siRNA-transfected HeLa cells 
displayed a significant reduction in the parasite invasion rate by 66% compared to th  
cells transfected with the scrambled control siRNA oligomer (Figure 3-2 A). This 
data suggests that SNAPIN plays an important role in the invasion process although 




   
Figure 3-2. Depletion of SNAPIN shows a s
(A) HeLa cells were transfected by either a control siRNA or a pool of snapin siRNA 
oligomers for 48 hours and infected by Y strain tissue
for 20 minutes. The infected HeLa cells were 
Giemsa. The number of intracellular parasites in 200 HeLa cells was counted twice 
under the microscope and averaged. Parasite invasion rate was reduced (66%) by 
SNAPIN depletion in HeLa cells as compared to the control. 
hashed column, snapin siRNA in a white column. (B) HeLa cells were prepared after 
being transfected with a control siRNA, a pool of snapin siRNA oligomers and each 
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of three snapin siRNA oligomers respectively. Cells were lysed with NP40-containing 
lysis buffer and total cell extracts were analyzed in SDS-PAGE gel followed by the 
standard immunoblotting with rabbit polyclonal anti-SNAPIN antibodies (upper panel) 
or rabbit polyclonal anti-β-tubulin antibodies (bottom panel) and anti-mouse HRP 
conjugated antibodies. The result confirms the efficiency of depletion in SNAPIN 
especially when HeLa cells were treated with a snapin siRNA pool. (C, D) 
Endogenous SNAPIN in HeLa cells was stained with mouse monoclonal anti-
SNAPIN and anti-mouse Alexa488 antibodies after transfecting HeLa cells with the 
control siRNA and a pool of snapin siRNA oligomers respectively. This 
Immunofluorescence Assays (IFA) result indicates a visual depletion of endg ous 
SNAPIN signal in HeLa cells after snapin siRNA transfection. (E, F) Giemsa-stained 
infected HeLa cells transfected with (E) the control siRNA or (F) a pool of snapin 
siRNA. White halo surrounding the parasites indicates the location inside the cell 












Figure 3-3. Deletion of snapin
SNAPIN WT and KO MEF cells were infected with Y strain tissue
trypomastigotes (TCTs) and incubated for 20 minutes followed by extensive wash 
with PBS. Infected MEF cells were stained with Giemsa and mounted on the 
microscope for the inspection. The number of intracellular parasites in 200 MEF cells 
was counted twice under the microscope and averaged. Parasite invasion rate was 
reduced by snapin deletion in SNAPIN KO MEF cells when compared to that in 
SNAPIN WT MEF cells. (B) The immunoblo
SNAPIN KO MEF total cell lysates confirms the absenc  of SNAPIN protein 
expression in MEF cells when probed with rabbit polyclonal SNAPIN antibodies. 
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this T. cruzi invasion assay. A similar invasion experiment was conducted using 
Snapin+/+ and snapin-/- MEF cells where Western blot analysis confirmed the ablation 
of SNAPIN expression (Figure 3-3 B). Under the same condition, the number of 
intracellular parasites in snapin-/- MEF cells dropped greatly by 45% when compared 
to that in Snapin+/+ MEF cells which is consistent with our previous RNAi data. In 
two independent experiments, SNAPIN was demonstrated to be involved in the T. 
cruzi invasion process. Particularly, SNAPIN-deficient cells resulted in an increased 
resistance to T. cruzi invasion. The plausible reason that we observed a moderate 
infection reduction in the snapin-/- MEF cells (45%) compared to that in SNAPIN-
depleted cells (66%) might be due to a compensatory pathway partially counteracti g 
the loss of SNAPIN in the snapin-/- MEF cells. 
3.3.2 Recruitment of SNAPIN to the parasite surface and the subcellular 
localization of SNAPIN to the late endosomes and lysosomes 
We next sought to determine the subcellular localization of SNAPIN during T. cruzi 
invasion of HeLa cells. Immunostaining of endogenous SNAPIN in HeLa cells 
revealed an intracellular perinuclear and punctate pattern (Figure 3-4 B) so we 
colocalized endogenous SNAPIN with several endosomal markers such as the 
recycling endosomal marker (Rab11-YFP), the early endosomal marker (Rab5-YFP), 
the late endosomal marker (Rab9-YFP), and the lysosomal marker (Lgp120-YFP or 
adenovirus encoding LAMP1-RFP) while T. cruzi Y strain infective trypomastigote is 
invading the HeLa cell. HeLa cells were either transfected with each plasmid 
encoding an endosomal marker or transduced with an adenovirus encoding a 




Figure 3-4. The immunostaining of SNAPIN in HeLa cells. 
proteins in HeLa cells were immunostaine
SNAPIN monoclonal antibodies coupled with rabbit anti
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Figure 3-5. SNAPIN is recruited to the parasite and colocalized with the late 
endosomes and lysosomes
RFP (E-H) were infected with Y strain metacyclic trypomastigo es (MTs) cells for 60 
minutes. Infected HeLa cells were fixed and stained with mouse monoclonal anti
SNAPIN antibodies followed by 
antibodies respectively for the inspection on the microscope (A
Nikon E200). (A and E) Nucleus of HeLa cells and the nucleus and kinetoplast DNA 
of the parasite are stained with DAPI shown in blue. (B and G
80 
. HeLa cells overexpressing Rab9-YFP (A-D) or LAMP1
anti-mouse Alexa594 or anti-mouse Alexa488 









localization of Rab9 (the late endosomal marker) in green and LAMP1 (lysosomal 
marker) in red respectively. (C and F) Endogenous SNAPIN subcellular localization 
in HeLa cells shown in red and green respectively. (D and H) Merged image reveals 
the colocalization of SNAPIN with the late endosomes and lysosomes respectively 
especially on the surface of the parasite shown in yellow (enlarged image is 
embedded). 
HeLa cells were infected with Y strain TCTs for 60 minutes and stained with mouse 
monoclonal anti-SNAPIN antibodies followed by rabbit anti-mouse Alexa488 
antibodies for endogenous SNAPIN localization during T. cruzi invasion. (I) DAPI 
staining in blue. (J) Endogenous SNAPIN (green) was recruited to the parasite 
surface. (K) Merged image. 
HeLa cells overexpressing Rab5-YFP were infected with Y strain TCTs for 60 
minutes and stained with mouse monoclonal anti-SNAPIN antibodies followed by 
rabbit anti-mouse Alexa594 antibodies. (L) DAPI staining in blue. (M) The early











trypomastigotes for 60 minutes 48 hours post transfection or transduction. 
Subsequently, cells were fixed with 4% fresh PFA, permeabilized and stained with 
mouse anti-SNAPIN monoclonal antibodies and inspected on the confocal 
microscope. Indeed, SNAPIN was recruited to the parasite surface (Figure 3-5) and 
largely col-localized with the late endosomes (Rab9) and lysosomes (adenovirus 
encoding LAMP1-RFP) as previously reported (Figure 3-5 A-H) (Lu, Cai et l. 2009; 
Cai, Lu et al. 2010). We also were able to observe that the early endosomes (Rab5) 
were recruited to the point of parasite entry (Figure 3-5 L-O) as previously shown 
elsewhere (Baud, Lovis et al. 2001) but not colocalized with endogenous SNAPIN. 
This data indicates that SNAPIN is associated with the parasite invasion process, 
more specifically a lysosome-dependent entry process rather than a non-lysosome 
dependent entry process engaging the early endosomes. 
3.3.3 Poor host lysosome recruitment to the parasite in SNAPIN-deficient 
MEF cells 
Abnormal accumulation and atypical subcellular distribution of immature lysosomes 
in snapin-/- neuron cells due to the defects in late endocytic trafficking were reported 
previously (Lu, Cai et al. 2009; Cai, Lu et al. 2010). We also have observed the 
similar phenotypes in snapin-/- MEF cells when compared to Snapin+/+ MEF cells 
(Figure 3-6). To visually examine how SNAPIN affects a lysosome-dependent T. 
cruzi invasion process, we performed the invasion assays by infecting Snapin+/+ nd 
snapin-/- MEF cells with T. cruzi Y strain tissue-culture derived trypomastigotes 
expressing GFP for 0, 20, and 40 minutes after extensive washing following an initial 




Figure 3-6. SNAPIN KO MEF cells display aberrant lysosome distribution. 
SNAPIN WT MEF cells (A) and SNAPIN KO MEF cells (B) were stained with 
mouse anti-LAMP1 (lysosomal marker) antibodies followed by rabbit anti
Alexa594 antibodies and inspected on the confocal microscope (Leica SP5X). 
SNAPIN WT MEF cell displays a 
SNAPIN KO MEF cell shows strikingly increased amount of lysosomes spread over 


















Figure 3-7. SNAPIN KO MEF cells display poor host lysosome recruitment to 
the parasites. SNAPIN WT MEF and KO MEF cells infected with Y strain tissue
culture derived trypomastigotes (TCTs) expressing GFP for 20 minutes were washed 
extensively in order to synchronize the entry of the parasite and fixed after 0 minute, 
20 minute, 40 minute furth
LAMP1 antibodies followed by rabbit anti
on the confocal microscope (Leica SP5X). (A) SNAPIN WT MEF cell shows normal 
recruitment of lysosomes (red) to the parasit
DAPI in blue. (B) SNAPIN KO MEF cells display poor recruitment of lysosomes to 
the parasites surface compared to SNAPIN WT MEFs 20 minutes post infection. (C) 
84 
 
er incubation. MEF cells were stained with mouse anti
-mouse Alexa594 antibodies and examined 







Lysosome pixel intensity surrounding the parasites in SNAPIN WT MEF (hashed 
column) and SNAPIN KO MEF (white column) cells was quantified and compared at 
each time point. Results are presented as means ± SE from 20 parasites invading























were fixed and labeled with anti-LAMP1 antibodies to monitor lysosomes at each 
time point. The mean pixel intensity of lysosomes surrounding a parasite invading the 
MEF cells was measured on the confocal microscope and analyzed. Interestingly not 
only the number of the intracellular parasites was significantly reduced in the snapin-/- 
MEF cells as we previously observed (Figure 3-3) but also poor host lysosomal 
recruitment to the parasites was displayed compared to the that of Snapin+/+ MEF 
cells over time despite the fact that substantially increased amount of lysosomes 
present in snapin-/- MEF cytosol was observed (Figure 3-7). T. cruzi is well known to 
use unusual mechanisms to invade the cell by exploiting the recruitment and fusion of 
host lysosomes with the plasma membrane at the point of parasite entry (Tardieux, 
Webster et al. 1992) and the poor host lysosome recruitment to the parasite may 
explain why T. cruzi invasion was significantly reduced in SNAPIN-deficient cells. 
Furthermore, a failure of the parasites to reside in the lysosome-like parasitophorous 
vacuoles (Andrade and Andrews 2004) may possibly lead to the critical defect in 
differentiation into the intracellular amastigotes, and intracellular srvival eventually.  
3.3.4 Reduced calcium-dependent lysosome exocytosis in napin-/- MEF 
cells 
It was very intriguing that the parasites showed an impaired recruitment of host 
lysosomes in snapin-/- MEF cells despite the massive accumulation of LAMP1-
positive lysosomes and its distribution spread throughout the cell cytosol. Host 
lysosome recruitment and fusion to the plasma membrane is a required event for T. 
cruzi to gain entry to the host cells (Tardieux, Webster et al. 1992). To figure out why 




Figure 3-8. SNAPIN KO MEFs are impaired in calcium dependent lysosomal 
exocytosis. Calcium-dependent lysosomal exocytosis in SNAPIN WT and KO MEF 
cells was assayed and compared in two independent experiments using different 
lysosomal enzymes, β-hexosaminidase and 
SNAPIN KO MEF cells show a great reducti
secretion after 10 µM ionomycin treatment compared to the SNAPIN WT MEF cells. 
(B) β-galatosidase secretion was also significantly inhibited in SNAPIN KO MEFs 
when the cells were treated with 10 
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β-galactosidase, respectively. (A) 
on in the rate of β-hexosaminidase 






MEF cells. (C and D) MEF cells do not display lysosomal exocytosis upon 10 µM 
ionomycin treatment in the absence of calcium in the culture media. Results are 
























lysosomes present in the cell, we examined the rate of calcium-dependent lysosomal 
exocytosis using two distinct lysosomal enzymes: β-hexosaminidase and β-
galactosidase. Both Snapin+/+ MEF cells and snapin-/- MEF cells were incubated in the 
presence or absence of 10 µM ionomycin and the amount of secreted lysosomal 
enzyme was measured using a colorimetric assay coupled with an appropriate 
substrate to each lysosomal enzyme. Ionomycin is a calcium ionophore that allows 
transporting calcium across biological membrane and thus increasing the intrac llular 
calcium level. The amount of secreted enzyme resulting from a calcium-dependent 
lysosomal exocytosis was normalized over the entire amount of the enzyme in the 
total cell lysates and compared. When compared to Snapin+/+ MEF cells, snapin-/- 
MEF cells revealed significantly reduced amounts of β-hexosaminidase and β-
galactosidase, 75% and 55%, respectively, that are secreted in the culture media upon 
ionomycin treatment in both independent experiments (Figure 3-8). This indicates 
that SNAPIN deficiency leads to an impaired calcium-dependent lysosomal 
exocytosis in the host cells and provides a clue how SNAPIN impacts the lysosome-
dependent parasites invasion process. This is interesting because SNAPIN-deficient 
cells display increased amount of LAMP-1 positive lysosomes, yet the vast majority 
of these LAMP-1 positive lysosomes is not functional for a calcium-dependent 
exocytosis. This data is in agreement with a previous study (Tian, Wu et al. 2005) 
showing SNAPIN deletion in neuron impairs calcium-dependent exocytosis. It was 
previously shown that snapin-/- neuron exhibits accumulation of immature lysosomes 
with impaired lysosomal function such as reduced clearance of autolysosomes (Cai, 




Figure 3-9. SNAPIN is translocated to the plasma membrane and exposed to the 
extracellular space. NRK cells were treated with 10 
and kept unpermeabilized when being stained with polyclonal anti
antibodies.  (A, B) In the absence of ionomycin, NRK cells do not expose SNAPIN to 
the extracellular space. (C, D) SNAPIN (in red), in a subset of NRK cells, 
translocated to the plasma membrane and exposed to the extracellular space in the 
















lysosome maturation and only the mature functional lysosome pool is used for a 
calcium-dependent exocytosis that will eventually benefit the parasite entry. The 
absence of SNAPIN accumulates the immature lysosomes that are not functional for a 
calcium-dependent exocytosis thus inhibits the parasite invasion. We had also 
observed a reduced GFP signal from several parasites expressing GFP that reside in 
the LAMP-1 positive parasitophorous vacuoles in Snapin+/+ MEF cells (Figure 3-7 A) 
whereas the parasite invading the snapin-/- MEF cells was expressing the bright GFP 
(Figure 3-7 B). It is very plausible that GFP was quenched by the low pH in the 
functional and mature lysosomes and the LAMP-1 positive lysosomes in the s apin-/- 
MEF cells are immature and not acidic enough to quench the GFP proteins in the 
invading parasite. 
3.3.5 SNAPIN is translocated and exposed to the extracellular space upon 
calcium influx 
The topology of SNAPIN in the endosomal membrane is yet to be fully understood 
but according to the previous in silico analysis (Gowthaman, Silvester et al. 2006), 
SNAPIN is predicted to have two helical domains, one of them at its far C-terminus is 
most likely to be a coiled-coil domain based on PARCOIL analysis (Figure 3-10). 
This coiled-coil domain was demonstrated to be responsible for most interactions 
with SNARE proteins and other proteins (Buxton, Zhang et al. 2003; Chen, Lucas et 
al. 2005; Bao, Lopez et al. 2008; Wei, Xu et al. 2010), hence is presumed to be facing 
towards the cytosol. Although we found that TMHMM failed to predict a potential 
transmembrane domain in SNAPIN, several biochemical and cellular studies 




Figure 3-10. Schematic representation of SNAPIN structure. 
prediction of SNAPIN secondary structure and (B) protein motifs were represented. 
Hydrophobic segment (HS, in blue box) and coiled coil (CC) indicated (modified 


















Figure 3-11. A pairwise interaction 
SNAPIN by yeast two-hybrid 
fragment of SNAPIN do not interact in the yeast two










between MASP and the luminal domain of 
(A) Both MASP1 & MASP4 and the N-terminal 
-hybrid system. B) Western blot 





SNAPIN (Buxton, Zhang et al. 2003; Chen, Lucas et al. 2005; Ruder, Reimer et al. 
2005; Suzuki, Morishima et al. 2007). This prediction posed a topological issue for us 
since we initially identified SNAPIN as a putative MASP interactor (Figure 2-5) that 
is on the surface of the parasites. We hypothesized that the luminal domain of 
SNAPIN is exposed to the extracellular space as a result of a calcium-dependent 
lysosomal exocytosis. To test this hypothesis, NRK cells were stimulated wi h 10 µM 
ionomycin for 10 minutes and labeled with anti-SNAPIN antibodies under conditions 
not permitting cell permeabilization. NRK cells were selected since thosecell  are 
easily elicited by ionomycin and exhibit a better lysosomal exocytosis. We were able 
to observe the massive translocation of SNAPIN to the plasma membrane upon 
calcium influx (Figure 3-7 C and D) under the nonpermeabilized condition indicating 
the luminal domain of SNAPIN is exposed to the extracellular space due to a 
calcium-dependent lysosomal exocytosis event. This result confirms our earlie
observation that SNAPIN is associated with lysosomes (Figure 3-5 E-H). Also this 
unravels the putative role of SNAPIN in T. cruzi invasion process possibly by 
providing the parasite the anchor or the target point for its entry. It is also worth 
noting that not all NRK cells responded to the stimulus and exposed SNAPIN to the 
extracellular space. This is in agreement with the observation that T. cruzi selectively 
invades a subset of cells and the distribution of T. cruzi infection obeys the negative 
binomial distribution rather than the Poisson-distribution (Dvorak and Hyde 1973; 
Fernandes, Cortez et al. 2011).  
We tested the interaction between MASP proteins and the N-terminal domain of 




was cloned in pGADT7g Y2H expression vector by Gateway® cloning system and the 
expression in yeast cell was validated and confirmed by the standard immunoblotti g 
analysis using anti-SNAPIN antibodies after transfection into yeast Y187 strain 
haploid cell. Unfortunately we were unable to show MASP1 nor MASP4 interacting 
with the N-terminal domain of SNAPIN in Y2H system. This might be one of a false 
negative that is one of disadvantages of Y2H system or may reflect the shortcoming 
of validating the protein-protein interaction in the heterologous system. 
3.4 Conclusions and significance 
SNAPIN seems to play a role in T. cruzi invasion process as T. cruzi infection is 
inhibited in SNAPIN-deficient cells. As we expected from MASP-SNAPIN 
interaction, SNAPIN was recruited to the parasite surface during the invasio  process 
and associated with the late endosomes and lysosomes suggesting that SNAPIN is 
involved in the lysosome-dependent parasite entry process. SNAPIN deletion led to 
an accumulation of immature and nonfunctional lysosomes in the cell cytosol and a 
decrease in host lysosome recruitment to the parasite surface due to an impaired 
calcium-depenent lysosome exocytosis. Upon induced calcium influx, SNAPIN is 
translocated to the plasma membrane of the cells and the luminal domain is exposed 
to the extracellular space that may provide an anchor to the parasite for its entry 
although the interaction between MASP and the N-terminal domain of SNAPIN was 
tested as negative. A set of experiments shown in this chapter gives the clues abo t 
not only the roles of SNAPIN in the context of cellular biology but also the functions 
of SNAPIN in the parasite invasion process and how parasites utilize the host proteins 




host cells can infer the function of parasite counterpart proteins and how useful this 
can be in T. cruzi gene annotation where 50% of the genes are still unannotated and 





Chapter 4: The investigation of a putative function for MASP in host 
cell invasion  
4.1 Objective of Study 
The overall objective of this study was to characterize the putative function of the
MASP family utilizing molecular genetics tools and cellular biological techniques. In 
Chapter 3, human interacting partner protein of MASP1 and MASP4, SNAPIN, was 
demonstrated to be involved in the T. cruzi invasion process by mediating the host 
lysosome maturation and calcium-dependent lysosomal exocytosis. In Chapter 4, we 
aimed to determine the role of MASP1 and MASP4 in the context of calcium-
dependent lysosomal exocytosis where SNAPIN was implicated via generating 
transgenic parasites that constitutively overexpresses recombinant MASPproteins in 
the kinetoplastid protozoan parasite, L ishmania tarentolae, not only the non-
pathogenic but also incapable to host cell invasion and down-regulating the MASP 
expression in T. cruzi by blocking the translation initiation site with the modified 
complementary oligomers. Even though we are focusing on only two MASP 
members out of 1,377 copies in the genome, the putative function determined from 
this study may apply to other members if MASP1 and MASP4 turn out to share the 
common role in T. cruzi invasion process. 
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Host cells and Parasites: HeLa cells (CCL-2.1) and LLC-MK2 (Rhesus Monkey 
Kidney Epithelial) cells were maintained in Dulbecco's Modification of Eagle's 
Medium (DMEM) supplemented with 10% heat inactivated Fetal Bovine Serum (FBS)
at 37ºC with 5% CO2. Trypanosoma cruzi epimastigotes (CL Brener and Y strains) 
were maintained in Liver Infusion Tryptose (LIT) medium with 10% heat inactivated 
FBS at 28ºC. Metacyclic trypomastigotes (MTs) of T. cruzi were purified from 10-
day old LIT culture by ion-exchange chromatography (DEAE cellulose) and Tissue-
culture derived trypomastigotes (TCTs) were obtained from infected LLC-MK2 cells. 
Leishmania tarentolae P10 strain (Jena Bioscience) was cultivated in Brain Heart 
Infusion (BHI) medium supplemented with 5 µg/ml Hemin at 26ºC. 
Over-expression of MASP in the L. tarentolae system: Pairs of restriction enzymes 
BglII & NheI and BglII & NotI were used to clone GFP and full-length internally 
6xHis-tagged MASP1 & MASP4 proteins into pLEXSY-sat2 vector respectively. 
The constructs were linearized with SwaI for the genomic integration into the 
chromosomal 18S rRNA locus and 5x107 L. tarentolae P10 strain in mid-log phase 
was electroporated using Gene Pulser II system (Bio-Rad) according to the 
manufacturer’s instructions. Twenty-four hours after electroporation, the transgenic 
populations were selected under 100 µg/mL Nourseothricin (NTC) for the generation 
of stable population. 
Purification of GPI-anchored recombinant MASP from L. tarentolae: GPI-
anchored recombinant MASP proteins were purified from the transgenic L. tarentolae 




and Thompson 1995; Anez-Rojas, Garcia-Lugo et al. 2006; Rojas, Garcia-Lugo et al. 
2008). The transgenic parasites were resuspended in a 10 mM Tris–HCl, 150 mM 
NaCl pH 7.4 buffer (TBS) with 2% Triton X-114 and incubated for 1 hour at 0ºC. 
The suspension was then centrifugated and the supernatant was kept at -20ºC for 24 
hours. The frozen supernatant was thawed at room temperature and incubated at 32ºC 
for 12 minutes to obtain the partition. The partition was spun at 3,000x g for 3 
minutes and the aqueous phase containing hydrophilic proteins was stored at -20ºC 
for the downstream analysis. The detergent phase was further washed in 3 volumes of 
TBS pH 7.4 contianing 0.06% Triton X-114 and kept at 0ºC for 10 minutes. The 
partition process was repeated once more, the aqueous phase was discarded and the 
detergent phase was mixed with 3 volumes of TBS pH 7.4 containing 0.06% Triton 
X-114 again. The suspension was incubated at 0ºC for 10 minutes and cleared by 
centrifugation at 13,000x g, 0ºC for 15 minutes. The pellet containing hydrophobic 
proteins was kept at -20ºC for the downstream analysis and the supernatant fractio  
was subjected to another partition. The detergent phase containing GPI-anchored 
proteins was precipitated with 4 volumes of cold acetone and resuspended in PI-PLC 
buffer (25 mM HEPES pH 7.5, 0.1% sodium deoxycholate). GPI-anchored proteins 
were cleaved by 1U PI-PLC (Invitrogen) for 3 hours at 37ºC. 6xHis-tagged MASP 
proteins in the aqueous phase were purified by Ni-NTA agarose resin. The proper 
fractionation and purification of 6xHis-tagged MASP proteins were confirmed by 
performing SDS-PAGE analysis followed by the standard immunoblotting analysis 




Leishmania tarentolae pull-down assay: Purified 6xHis-tagged L. tarentolae 
recombinant MASP protein was used as bait and the c-Myc-tagged full-length 
SNAPIN, N-terminal fragment of SNAPIN, and Bcl-2 recombinant proteins were 
expressed in HeLa cells and used as prey. The c-Myc plasmids were constructed by 
Gateway® recombination. Open reading frames (ORFs) of full-length snapin, N-
terminus of snapin, bcl-2 were amplified by the polymerase chain reaction using the 
Pfx50™ DNA polymerase using the primers (See Appendix B.1 for sequence) with 
attB overhang sequences that served as the recombination sites. Amplicons were 
cloned into the pDONR™/Zeo vector and then the inserts were shuttled to pDEST-
CMV-c-Myc vector by LR reaction (Invitrogen) according to the manufacturer’s 
instructions. The interaction pairs, 6xHIS-baits (6xHIS-MASP1 and 6xHIS-MASP4) 
and c-Myc-preys (c-Myc-Bcl2, c-Myc-SNAPIN and c-Myc-Luminal SNAPIN) were 
incubated for 1 hour at 4ºC. The complexes were purified by Ni-NTA agarose resin 
and analyzed by SDS-PAGE and the standard immunoblotting techniques with mouse 
anti-His antibodies and mouse anti-c-Myc antibodies. 
Immunofluorescence: LLC-MK 2 cells infected by T. cruzi were fixed with 4% fresh 
paraformaldehyde (PFA) for 10 minutes at room temperature, washed with PBS 3 
times, and quenched with 15 mM NH4Cl. The samples were then blocked with 2% 
BSA-containing PBS for 1 hour at room temperature. Cells on the glass coverslip 
were permeabilized with 0.1% Saponin for 10 minutes if necessary. The samples 
were incubated with mouse anti-His monoclonal antibodies for 1 hour followed by 
anti-mouse Alexa Fluor 488 secondary antibody incubation. Images were acquired 




of Maryland, College Park). For L. tarentolae, the cells were fixed in 4% fresh PFA 
and washed with PBS 3 times followed by 50 mM NH4Cl. The fixed cells were 
spotted on a glass slide and allowed to dry for 30 minutes at room temperature. The 
dried cells were rehydrated with PBS twice for 10 minutes each and blocked for 1 
hour with 3% BSA in PBS. The slide was incubated with mouse anti-6xHis 
monoclonal antibodies at 1:100 dilution for 1 hour with no cell permeabilization step 
and then with anti-mouse Alexa Fluor 594 secondary antibodies at 1:500 dilution. 
The samples on the slide were inspected on the confocal microscope (Leica SP5 X) 
in the imaging core facility (University of Maryland, College Park). 
Live cell imaging and calcium transient analysis: HeLa cells (1x105) were seeded 
on Lab-Tek™ Chamber Slides and preloaded with the green-fluorescent calcium 
indicator, Fluo-4 for 30 minutes at 37ºC followed by another 30 minutes at room 
temperature on the following day. The Fluo-4-preloaded cells in the chamber slides 
were incubated with 2x107 T. cruzi CL Brener strain trypomastigotes, L. tarentolae 
P10 strain, and transgenic P10 strains expressing MASP1 or MASP4. For the 
experiments with polystyrene beads, Fluo-4-preloaded HeLa cells were incubated 
with BSA-coated polystyrene particles, MASP1-coated polystyrene particles, and 
MASP4-coated polystyrene particles. Cells were live-imaged every 213 ms over 300 
sec on the confocal microscope (Leica SP5 X) in the imaging core facility 
(University of Maryland, College Park). Intracellular calcium transie ts in 100 HeLa 
cells (color-coded) were monitored and plotted over time using the Leica LAS AF 





MASP proteins-coated particles were prepared by passive adsorption. Purified 
recombinant MASP proteins were incubated with 0.1M phosphate buffer (pH 7.4) 
and 5% w/v 0.7~0.9 µm polystyrene particles. The mixture was incubated for one 
hour at room temperature. The supernatant was removed carefully after 
centrifugation for 15 minutes at 3,000x g. Isotonic Buffered Saline (IBS) was added
and the mixture was vortexed well. The supernatant was once again removed by 
centrifugation for 15 minutes at 3,000x g. The particles were resuspended with IBS 
and the suspension was used for the experiments.  The efficiency of passive 
adsorption was confirmed by immunofluorescence assays using mouse anti-His 
mono clonal antibodies coupled with Alexa Fluor 594 secondary antibodies and 
inspected under Nikon epifluorescence microscope (E200). 
Cell wounding assay: HeLa cells (2x106) were incubated with L. tarentolae wild-type 
P10 strain, or transgenic P10 strains expressing MASP1 or MASP4, in the absence of 
Ca2+ in DMEM with 25 µg/ml propidium iodide (PI) for 30 minutes at 37ºC. Cells 
were fixed with 4% fresh PFA for 10 minutes and stained with DAPI (4',6-diamino-
2-phenylindole). The plasma membrane integrity was inspected on Nikon 
epifluorescence microscope (E200) by counting PI-positive cells. 
MASP adhesion assay: Transgenic L. tarentolae cells (6x107) expressing MASP1 
or MASP4, along with wild-type L. tarentolae were incubated with 2x106 HeLa cells 
(MOI=30) for 1 hour and washed extensively with PBS 5 times. The cells were fix d 
in Bouin’s fixative for 20 minutes at room temperature and washed with PBS 5 times 
thoroughly.  Cells were stained with Giemsa solution overnight and mounted on the 




Cell protection from complement lysis assay: L. tarentolae P10 strain and transgenic 
parasites expressing MASP1 or MASP4 were incubated in BHI medium with 10% 
Horse Serum for 2 hours or 4 hours. The number of viable cells was determined by 
CellTiter 96 AQueous Non-Radioactive Cell Proliferation Assay at each time point 
according to the manufacturer’s instructions. 
Knock-down attempts of GP72 in T. cruzi using morpholino: Morpholino oligo 
sequence (5’-TGAAAACATCACGTCCAAGACGGGA-3’) was synthesized 
according to the manufacturer’s recommendation to efficiently block the translatio  
of T. cruzi GP72 by targeting from 16 bases upstream of start codon to 9 bases 
downstream of start codon. 100 µM of GP72 morpholino oligomers was transfected 
into 5x107 mid-log phase T. cruzi CL Brener strain epimastigotes with Basic Parasite 
Nucleofector® Starter Kit by Nucleofector™ II Device, program U-033 (Lonza). The 
same amount of Nucleofector® solution without morpholino oligomers was used as a 
negative control. The morphology of the transfected parasites was monitored up to 
48 hours on Nikon epifluorescence microscope (E200).  
4.3 Results and Discussion 
4.3.1 The overexpression of MASP in Leishmania tarentolae  
Recombinant MASP proteins used in our earlier assays were expressed in a variety of 
heterologous systems (Figure 2-1). Our attempts to overexpress recombinant MASP 
proteins in T. cruzi resulted in very low expression levels observed by 
immunoblotting (data not shown) and immunostaining analyses (Figure 5-6 A), 




Figure 4-1. Leishmania tarentolae
6xHis-tagged masp1 and 
tranfected into (B) Leishmania tarentolae
to overexpress MASP in L. ta
splicing as well as poly-adenylation 
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 expression system (LEXSY). (A) Internally 
masp4 ORFs were cloned in pLEXSY-2 vector and 
 P10 strain. (C) pLEXSY-2 vector was used 
rentolae. utr1, utr2 and utr3 contain efficient trans







TcDHH1 protein, a DEAD box RNA helicase, was recently implicated to regulate the 
expression of MASP in the epimastigote stage, by directly binding to MASP 
transcripts and inhibiting the translation of MASP in the epimastigote stage (Hol tz, 
Alves et al. 2010). Therefore, it was very tricky to work with recombinant MASP 
proteins in T. cruzi because MASP expression seemed to be strictly controlled in the 
replicative epimastigote form and even under one of the strongest promoters, 
ribosomal DNA, the expression of MASP was not detectable in the epimastigote form. 
Although MASP expression was found in the trypomastigote form, considering 
multiple endogenous MASP proteins already present in the surface of wild-type 
trypomastigotes, it was not ideal to compare the transgenic trypomastigotes 
expressing MASP protein to wild-type trypomastigotes.  
Thus, we evaluated recombinant MASP proteins overexpression in a related 
kinetoplastid, L. tarentolae as this is a well-established overexpression system for 
trypanosome proteins and represents a relatively homologous system (Breitling, 
Klingner et al. 2002; Heise, Singh et al. 2009; Bolhassani, Taheri et al. 2011) to T. 
cruzi. L. tarentolae belongs to the Leishmania genus and the Trypanosomatidae 
family where T. cruzi is included. Unlike other pathogenic Leishmania spp. and 
trypanosomes, L. tarentolae is non-human pathogenic and lives predominantly as an 
extracellular promastigote form in lizard (Baud, Lovis et al. 2001). L. tarentolae 
overexpression system has several advantages over others that we have tried in the 
previous studies including a large quantity protein yield, and a much better likelihood 
of correct protein folding and ‘native’ post-translational modifications (Breitling, 




Figure 4-2. Recombinant MASP expression in 
tagged MASP1 and MASP4 were expressed in 
Each fraction was analyzed by Western blot revealing that MASP proteins are 
enriched in a GPI-anchored protein fraction. (B) GPI
fraction was prepared by Triton X
materials and methods. (C) The subcellular localization of recombinant MASP 












Leishmania tarentolae P10 strain. 
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on the plasma membrane can be used along with wild-type L. tarentolae and 
compared to each other to investigate the putative function of MASP as recombinant 
MASP protein is expressed constitutively in the promastigote form and has no 
orthologs in L. tarentolae. Hence we introduced L. tarentolae expression system 
(LEXSY) in order to obtain reliable amount of recombinant 6xHis-tagged MASP 
proteins presumably folded and modified in a very similar fashion to that in T. cruzi 
(Figure 4-1 A). The full-length masp1 and masp4 harboring 6xHis-tag in the 
hypervariable region were cloned into pLEXSY-sat2 expression vector. The wild-
type L. tarentolae P10 strain (Figure 4-1 B) was transfected with the linearized DNAs 
for the genomic integration and the transgenic parasites expressing MASP proteins 
were selected using Nourseothricin (NTC). Stable population of L. tarentolae P10 
strain expressing 6xHis-tagged MASP1 and MASP4 were subjected to the 
immunofluorescence assay using mouse anti-His monoclonal antibodies and the 
cellular localization was clearly confirmed to the plasma membrane, presumably by 
GPI-anchor whereas no 6xHis-tagged protein expression was detected in L. 
tarentolae P10 strain as expected (Figure 4-2). This L. tarentolae expressing MASP 
proteins on the surface became a powerful tool in our hands allowing production of 
large amounts of MASP proteins and providing us with a live transgenic 
trypanosomatid expressing MASP. The purification of recombinant MASP proteins 
was performed by Triton X-114 (TX-114) fractionation (Figure 4-3) (Ko and 
Thompson 1995; Anez-Rojas, Garcia-Lugo et al. 2006; Rojas, Garcia-Lugo et al. 
2008).  Triton X-114 is a unique mild nonionic detergent that not only solubilizes 




Figure 4-3. GPI-anchored protein partitioning pipeline using Triton X
(modified from 1995 Ko 
TBS containing 2% Triton X
separate membrane proteins (A). Supernatant was tran ferred to the new tube and 
partitioned at 32ºC into aqueous phase (B: hydrophilic proteins) and detergent phase.
The detergent phase was washed in TBS containing 0.06% TX
partitioned. The aqueous phase was discarded and the de ergent phase was 
centrifugated to separate hydrophobic proteins (C). The supernatant was transferred 








et al. BJ). L. tarentolae expressing MASP wer  lysed in 
-114 (TX-114) and the cell lysates were spun down to 









Figure 4-4. Immunoblotting analysis of each fraction from Triton X-114 
partitioning. Membrane (A), hydrophilic (B), hydrophobic (C) and GPI-anchored 
proteins (D) of L. tarentolae wild-type, L. tarentolae expressing MASP1 and MASP4 















Figure 4-5. Purification of GPI-anchored MASP proteins. GPI-anchored MASP 
proteins were cleaved by PI-PLC enzyme to be released from the detergent phase (D) 














partitioning at room temperature. This is very useful for protein fractionation because 
TX-114 solution is homogeneous at 0ºC as a clear micellar solution but separates into 
an aqueous phase and a detergent phase above 20ºC as micellar aggregates form and 
the solution turns turbid. With increased temperature, phase separation proceeds until 
two clearly separated phases are formed where hydrophilic proteins are enriched in 
the upper aqueous phase and hydrophobic proteins are enriched in the bottom 
detergent phase. First, L. tarentolae parasites were lysed in 2% TX-114 solution and 
membrane proteins were solubilized.  The total cell lysates were partitioned nto 
membrane, hydrophilic, hydrophobic and GPI-anchored protein fractions (See 
Methods for a detailed preparation steps) (Figure 4-3). Each fraction obtained from 
TX-114 fractionation was analyzed by the standard immunoblotting technique using 
anti-His antibodies. As expected, the vast majority of 6xHis-tagged MASP proteins 
(MASP1 and MASP4) were detected in the GPI-anchored protein enriched fraction 
(Figure 4-4 D) indicating MASP proteins were processed properly in L. tarentolae 
overexpression system. However, small amounts were found in hydrophobic protein 
fraction (Figure 4-4 C) demonstrating MASP proteins are hydrophobic presumably 
because they are still anchored to the outer leaflet of the plasma membrane by GPI-
anchor. GPI-anchored MASP proteins were not present in membrane protein fraction 
confirming the efficiency of TX-114 in solubilizing and enriching GPI-anchored 
proteins (Figure 4-4 A). In order to make our MASP proteins soluble, MASP protein 
pellet from acetone precipitation step was resuspended in PI-PLC buffer and 
incubated with 1U of PI-PLC enzyme for 3 hours at 37ºC. PI-PLC cleaves a 




Figure 4-6. A luminal domain of SNAPIN is interacting with MASP proteins. 
6xHIS-tagged MASP1 and MASP4 proteins (baits) expressed in 
tarentolae were prepared as described earlier and incubated with the HeLa cell lysates 
where c-Myc-taged BCL2, SNAPIN and a luminal domain of SNAPIN (preys) were 
overexpressed respectively for 1 hour. The protein complex was purified with Ni
NTA agarose and analyzed by the standard immunoblotting analysis. (A) 6xHIS
tagged MASP1 and MASP4 were expressed a
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of the membrane bilayer. For both MASP1 and MASP4 proteins, we were able to 
observe the shift from the detergent phase to the aqueous phased after PI-PLC 
treatment (Figure 4-5) and soluble 6xHis-tagged MASP1 and MASP4 proteins were 
further purified by Ni-NTA agarose resin to remove other endogenous GPI-anchored 
proteins present in the membrane of L. tarentolae from GPI-anchored protein 
enriched fraction. PI-PLC treatment clearly showed the release of soluble MASP 
proteins from the plasma membrane indicating recombinant MASP proteins were 
indeed GPI-anchored (Figure 4-4 and 4-5). 
4.3.2 The luminal domain of SNAPIN interacts with the MASP proteins 
Purified and soluble recombinant MASP proteins expressed in L. tarentolae were 
used to evaluate their interaction with the luminal domain of c-Myc-tagged SNAPIN 
expressed in HeLa cells simulating the most biologically and topologically relevant 
environment for the host-parasite interaction. A pair of MASP and SNAPIN or a 
luminal domain of SNAPIN was mixed and incubated at 4ºC overnight. The protein 
complex was purified by Ni-NTA agarose resin and subjected to the standard 
immunoblotting analysis. The results demonstrate both MASP1 and MASP4 interact 
with the luminal domain of SNAPIN as well as the full-length SNAPIN (Figure 4-6 B) 
but not with BCL2, a negative control. This contrasts with the results that we got 
from Y2H system where we were not able to detect an interaction between MASP1 or 
MASP4 and the luminal domain of SNAPIN (Figure 3-11). Interestingly, both MASP 
proteins also interact with the C-terminal fragment of SNAPIN, which contains he 
cytosolic coiled-coil domain (data not shown). This may suggest other roles for 




Figure 4-7. Preliminary 
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modulate the lysosome exocytosis or when the parasite redifferentiates into the 
trypomastigote after nine rounds of binary division. Purified MASP proteins were 
also used for in vitro pull-down assays with human total cell lysates followed by mass 
spectrometry so we can confirm the interaction identified from Y2H screens and 
discover novel interactions (Figure 4-7 A). HeLa cells were lysed and incubated with 
Ni-NTA agarose resin to eliminate non-specific bindings to the resin in the absence of 
MASP proteins. Then, each MASP protein was incubated with the pre-cleared HeLa 
cell lysates at 4ºC overnight. The protein complex was recovered by Ni-NTA agarose 
resin and analyzed on SDS-PAGE. Even with the extensive clearance of non-specific 
bindings in HeLa cell lysates, Coomassie blue staining of PAGE gel revealed 
multiple bands in MASP pull-down lanes (Figure 4-7 B, lane 2 and 3) that are shown 
to be non-specific bindings when compared to the lane where pre-cleared HeLa total 
cell lysates were loaded (Figure 4-7 B, lane 1). This indicated that the fur r 
optimization was being required.  
4.3.2 MASP expressed in Leishmania tarentolae triggers calcium transients, 
probably by wounding the host cell membrane 
T. cruzi-specific MASP family was speculated to play a major role in the interaction 
of the parasite with the host cell, as T. cruzi has the unique characteristics to actively 
invade any nucleated cells among the Tritryps (Schenkman, Robbins et al. 1991; El-
Sayed, Myler et al. 2005). Also MASP is preferentially expressed in the infective 
form of T. cruzi on the surface (Bartholomeu, Cerqueira et al. 2009). In my earlier 
experiments in Chapter 3, MASP’s putative human partner protein, SNAPIN, was 




Figure 4-8. T. cruzi trypomastigotes induce a calcium transient in HeLa cells. 
HeLa cells were preloaded with Fluo
incubated with (A) DMEM media alone and (B) CL Brener stain trypomastigotes. 
Cells were imaged live every 200 ms over 5 minutes. Intracellular calcium 
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Figure 4-9. MASP triggers intracellular free calcium [Ca
cell. HeLa cells were preloaded with Fluo
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Figure 4-10. T. cruzi trypomastigotes trigger a calcium transient more frequently 
than L. tarentolae expressing MASP. 
the calcium transients in HeLa cells (12 out of 100HeLa cells) was higher than that 
of L. tarentolae expressing MASP (5 out of 100 HeLa cells).
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regulating a calcium-dependent lysosomal exocytosis. We next examined if 
transgenic L. tarentolae expressing GPI-anchored MASP proteins on the surface can 
trigger intracellular free calcium transient. Intracellular calcium increase was shown 
to be an event required for the host lysosomal exocytosis (Caler, Vaena de Avalos et 
al. 1998; Rodriguez, Martinez et al. 1999). HeLa cells were preloaded with Fluo-4, a 
fluorescent calcium indicator, 1 hour prior (30 minutes at 37ºC and another 30 
minutes at room temperature protected from the light) to the experiment and 
incubated with either wild-type parasites or the transgenic parasites expressing 
recombinant MASP proteins (MOI=200). Intracellular calcium concentration in each 
field (around 20 HeLa cells per field) was monitored by live imaging over 5 minutes 
on the confocal microscope (Leica SP5X). Interestingly, calcium transients w re only 
observed in HeLa cells incubated with the transgenic L. tarentolae overexpressing 
MASP proteins in a frequency of around 1 out of 20 HeLa cells monitored for 5 
minutes (5%) whereas none were observed when the cells were exposed to wild-type 
parasites (0%) in the same conditions (Figure 4-9). Among 500 HeLa cells surveyed, 
25 times of the calcium transients were observed when incubated with the transgenic 
L. tarentolae overexpressing MASP proteins. These results implicate MASP as the 
likely cause of the observed intracellular free calcium transients in the host cells since 
wild-type L. tarentolae did not evoke any calcium transients in 500 HeLa cells that 
were monitored in the same experimental conditions. This observation is reminescent 
of similar transients observed when T. cruzi CL Brener strain trypomastigotes were 
incubated with Fluo-3-preloaded HeLa cells and triggered a calcium transient i  




Figure 4-11. MASP-coated polystyrene beads induced the calcium transients in 
the host cells. Immunostaining images of A) BSA
(0.7~0.9 µm) B) MASP1-




-coated polystyrene particles 
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and Alexa Fluor 594 secondary antibodies. D) The number of Fluo-4 preloaded HeLa 

























Figure 4-12. MASP may wound the host cell plasma membrane. 
preloaded with 25ug/ml PI in calcium
Leishmania tarentolae P10 strain (C and D) P10 strains expressing 6xHIS
MASP1 and (E and F) MASP4 
inspected under the epifluorescent microscope (E200) and the number of PI
cells per 200 HeLa cells was
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observations in the T. cruzi trypomastigotes where multiple endogenous MASP 
members are present on the surface, we incubated Fluo-4-preloaded HeLa cells with 
T. cruzi CL Brener strain trypomastigotes (MOI=200) and monitored the changes in 
an intracellular calcium concentration over 5 minutes. Compared to that induced by 
the transgenic L. tarentolae overexpressing MASP proteins, much more frequent 
calcium transients were observed when HeLa cells were incubated with the 
trypomastigotes at a rate of 1 out of 8 HeLa cells (12%) (Figure 4-8 and 4-10). The 
difference (12% and 5%) between T. cruzi trypomastigote-induced calcium transient 
frequency and transgenic L. tarentolae expressing MASP-induced calcium transient 
frequency was expected and can be attributed to the fact that T. cruzi is still likely to 
express and fold its native MASP proteins more accurately, among multiple other 
MASP proteins in their proper context and other T. cruzi-specific surface proteins. To 
investigate a more direct connection between MASP proteins and the calcium 
transients in the host cells, MASP1 and MASP4-coated beads were prepared by 
passive adsorption using the purified recombinant MASP proteins overexpressed in L. 
tarentolae. The efficiency of the passive adsorption coating was validated by the 
immunofluorescence assays with anti-His antibodies and bovine serum albumin 
(BSA)-coated beads were purchased and included as a negative control (Figure 4-11 
A-C). MASP-coated and BSA-coated control beads were incubated with Fluo-4-
preloaded HeLa cells and the intracellular calcium concentration in the HeLa cells 
was monitored for 5 minutes. As expected, BSA-coated beads did not trigger any 
calcium transients. However, the calcium transients were observed in HeLa cells 




demonstrating that MASP may be the direct cause of the calcium transients in the 
host cells. In each experiment with protein-coated beads, 250 HeLa cells wer 
monitored and no transient intracellular calcium increase was observed with BSA-
coated beads (0%) whereas 1.7 in 100 HeLa cells (1.7%) and 1.1 in 100 HeLa cells 
(1.1%) displayed the calcium transients by MASP1-coated beads and MASP4-coated 
beads, respectively. The frequency of the host calcium transients caused by MASP-
coated beads was lower than that of transgenic L. tarentolae expressing recombinant 
MASP proteins-induced calcium transients (around 5 occurrences in 100 HeLa cells, 
Figure 4-10). This demonstrates that MASP protein itself is sufficient to trigger the 
calcium transients in the host cells even at a low rate but the active motility of the 
parasites may help increase the efficiency of the calcium transients caused by MASP 
proteins. Or further optimization of extensive MASP coating might be necessary 
(Figure 4-11 B, C) to increase the frequency of the calcium transients. 
To further determine whether this intracellular free calcium transient is caused by 
calcium influx from the extracellular space or calcium release from the in ernal store, 
we validated the plasma membrane integrity while HeLa cells were incubated with 
the parasites. HeLa cells were incubated with the parasites in the calcium-free media 
(plasma membrane non-repair condition) containing 25 µg/mL propidium iodide (PI), 
a membrane-impermeable dye (Fernandes, Cortez et al. 2011). The calcium was 
intentionally omitted from the culture media to prevent host cells from resealing the 
injury through a calcium-dependent lysosomal exocytosis (Tam, Idone et al. 2010; 
Fernandes, Cortez et al. 2011). HeLa cells incubated with transgenic L. tarentolae 




indicating recombinant MASP proteins are mechanically wounding the cell 
membrane whereas almost none (0.1%) were PI-stained when incubated with L. 
tarentolae wild-type parasites (Figure 4-12 A-F). All together this set of data
demonstrates that MASP may trigger intracellular free calcium transients presumably 
by injuring the host cell membrane to initiate the calcium-dependent lysosome 
exocytosis. Calcium release from internal stores as a result of calcium infl x from the 
extracellular space (calcium-induced calcium release) cannot be ruled out. Tw  
consecutive calcium transients observed in our previous experiments using Fluo-4 
support the possibility (Figure 4-8 B, left panel). This calcium-dependent lysosome 
exocytosis will lead to the exposure of the luminal domain of SNAPIN to the 
extracellular space for the interaction with MASP on T. cruzi to occur. This may 
provide an anchor for T. cruzi to stay in vicinity of the host cell for its entry.  
4.3.3 Examination of other putative functions of MASP  
In addition, the parasites expressing MASP proteins were showing significantly 
higher adherence to the host cells (around 90 parasites per 200 HeLa cells) than the 
wild-type parasites (around 43 parasites per 200 HeLa cells) when they were 
incubated with HeLa cells (Figure 4-13). This confirms the in silico prediction of 
multiple glycosylation sites on the MASP sequence and suggests T. cruzi may utilize 
the glycosylated MASP protein as an adhesion molecule such as gp82 to better attach 
to the host cells. Trans-sialidases (TSs) are the largest gene family in T. cruzi and one 
of their known functions is providing protection against the host complement lysis 
pathway by binding to complement factors C3b and C4b and inactivating them. We 




Figure 4-13. MASP enhances the adherence to the host cells. 
type and L. tarentolae expressing MASP proteins were incubated with HeLa cells. 
After extensive washing, the number of parasites attached to 200 HeLa cells were 



















Figure 4-14. MASP does not seem to protect the parasite from the complement 
lysis. L. tarentolae wild-type and 
incubated with 10% horse serum for (A) 2 hours and (B) 4 hours respectively and the 













complement lysis as MASP is predominantly expressed in the bloodstream form of T. 
cruzi. Wild-type L. tarentolae and transgenic L. tarentolae expressing MASP proteins 
were incubated in BHI media in the presence of 10% Horse Serum for 2 hours and 4 
hours. The number of viable parasites were measured by the colorimetric assays nd 
compared to each other (Figure 4-14). It turned out that L.t rentolae expressing 
MASP proteins does not confer significant resistance to the complement lysis when 
compared to wild-type L. tarentolae suggesting MASP does not provide the 
protection to the parasites from the host complement lysis. 
4.3.4 Gene down-regulation in T. cruzi by morpholino oligomers 
In an effort to down-regulate the expression of MASP family in T. cruzi, we decided 
to try morpholino oligomers which are antisense modified nucleic acid analogs to 
block access of ribosomes to the translation initiation site. Although there are no 
reports of utilizing morpholino oligomers in T. cruzi, the approach was succesfully 
used in T. brucei as a comparison to downregulation by RNAi. To examine if 
morpholino works in T. cruzi, we chose a gene that has a visible knock-down 
phenotype and tested it before its application to MASP family. GP72 is T. cruzi 
surface glycoprotein which phenotype was previously described by gene deletion 
experiments. A null mutant parasite had a detached flagellum and this abnormal 
flagellar phenotype persisted during the life cycle. We synthesized the morpholino 
oligomers targeting the gp72 translation initiation site from 16 bases upstream of start 
codon to 9 bases downstream of start codon and transfected into epimastigotes. 
Twenty-four hours post transfection, the parasites were inspected under the 













Figure 4-15. The morpholino pilot study in T. cruzi. The morphology of T. cruzi 
epimastigotes 24 hours after transfection. (A) T. cruzi transfected with the equal 
amount of the transfection solution. (B) T. cruzi transfected with 100 µM of 
























morpholino was delivered but similar phenotype was also found in the negative 
control where the same amount of transfection solution was transfected (Figure 4-15 
A, B). It is likely that the observed abnormal morphologies are simply the result of 
the transfections, which typically seem to stress T. cruzi. It was therefore difficult to 
draw the conclusion that the phenotype shown by the parasites transfected with the
morpholino oligomers is directly connected to targeted gene, gp72. Hence, the 
morpholino technology seems to be not feasible for T. cruzi unless there are 
improvements in T. cruzi transfection or delivery methods. 
4.4 Conclusions and significance 
MASP seems to be triggering a calcium transient presumably by directly wounding 
the host cell membrane. Intracellular calcium increase either by calcium influx or 
calcium induced calcium release from the internal stores initiate the calcium 
dependent lysosome exocytosis leading to the exposure of the SNAPIN luminal 
domain to the extracellular space. With the aid of interaction between MASP and a 
luminal domain of SNAPIN, T. cruzi may be able to stay in the vicinity of the host 
lysosome exocytosis site and better take advantages of complement endocytosis for 
its entry into the cells. It remains unclear how MASP protein can directly injure the 
host cell membrane. The structural study using crystallized MASP protein may be 
able to help us understand the mechanism.   
The function of MASP was not documented before and only speculated based on the 




invasion process by exploiting non-pathogenic L. tarentolae overexpression system 





















Chapter 5: A preliminary study of the expression profile of masp 
family genes and novel regulatory element(s) within masp coding 
sequence 
5.1 Objective of Study 
In addition to the massive expansion of the masp family in T. cruzi, suggesting an 
important role of MASP in T. cruzi biology, the ability of T. cruzi to invade any 
nucleated cell demonstrates a strategy to invade and adapt to different the host cell 
environments. Our previous data, including the trypomastigote cDNA library study 
and the immunofluorescence assay using anti-MASP peptide 7 antibodies 
(Bartholomeu, Cerqueira et al. 2009), strongly suggest that MASP expression 
includes only a subset of members at a time. We aimed to investigate the MASP 
expression profile in distinct host cells and determine if it correlates with the ost cell 
selection via the trypomastigote cDNA library screening both in a small-scale and a 
large-scale studies using a conventional Sanger sequencing method and next-
generation sequencing technology.  
MASP expression was shown to be tightly regulated (Bartholomeu, Cerqueira et al. 
2009; De Pablos, Gonzalez et al. 2011; De Pablos and Osuna 2012) and recently 
TcDHH1, a DEAD box RNA helicase, was demonstrated to play a role in differential 
expression of MASP in the epimastigote stage (Holetz, Alves et al. 2010). We aimed
to identify the regulatory element(s) involved in differential expression of MASP.  
The following works are incomplete, yet significant, experiments to be further 
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SuperScript® II Reverse Transcriptase 18064-014 Invitrogen 
TRIzol® Reagent 15596-026 
RNase H 18021-071 
Zero Blunt® TOPO® PCR Cloning Kit 450245 
One Shot® TOP10 Chemically Competent E.
coli 
C4040-03 
SuperScript® III Reverse Transcriptase (SS® III 
RT) 
18080-044 
Penicillin-Streptomycin solution 15070-063 
DNase I (RNase-free) M0303L New England 
Biolabs T4 DNA ligase M0202S 
DNA Polymerase I M0209L 
DEPC (Diethylpyrocarbonate) -treated water 786-117 G-Biosciences 
Heat-inactivated Fetal Bovine Serum (FBS) BW14-
503F 
Lonza 
RNeasy Mini Kit 74104 Qiagen 
NucleoSpin® Plasmid 740588 Macherey Nagel 
TruSeqTM RNA sample preparation kit  Illumina 












XbaI R0145 New England 
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Preparation of the parasites and the host cells: A 10-day old T. cruzi CL Brener 
strain epimastigote culture in LIT media at 28ºC was used for the purification of 
metacyclic trypomastigotes (MT) by DEAE cellulose affinity chromatography. 
Semiconfluent HeLa ATCC CCL-2.1 and LLC-MK2 cells were passaged on the 
monolayer in DMEM media supplemented with 10% heat-inactivated FBS and 1X 
Penicillin-Streptomycin solution. The cells were cultured at 37ºC in a humid 
atmosphere with 5% CO2. 
T. cruzi infection: Purified MTs were counted on the hemocytometer and prepared in 
a concentration of 1x107 tryps/mL in DMEM suspension. HeLa cells and LLC-MK2 
cells with 90% confluency were infected with 1x107 tryps for 1 hour. Subsequently, 
the cultures were washed with DPBS and the infected cells were incubated at 37ºC
with 5% CO2 for 5 days. Tissue-culture derived trypomastigotes (TCTs) emerging 
from HeLa and LLC-MK2 cell cultures were collected separately and spun down at 
4,000x g for 10 minutes. The cell pellet was resuspended in DMEM and the number 
of TCTs was counted on the hemocytometer. Equal number of purified MTs was 
collected and used as a control. 
Total RNA preparation: Total RNA was extracted using TRIzol® (Invitrogen) and 




contamination. Extracted total RNA was purified by RNeasy Mini Kit (Qiagen) 
according to the manufacturer’s instructions and resuspended in 60 µL DEPC-treated 
water. The quality and quantity of total RNA from MTs (A260/280 ratio: 2.0, 
concentration: 40 ng/µL), TCTs emerging from HeLa cells (A260/280 ratio: 2.1, 
concentration: 170 ng/µL) and LLC-MK2 cells (A260/280 ratio: 2.1, concentration: 
140 ng/µL), were measured using a NanoDrop ND-1000 spectrophotometer. 
1st strand cDNA synthesis: MASP 3’UTR-specific oligomer (MASP 3RT: 5’-
GTGTGCTTCGTGGGGTGAGGTG-3’) was used for oligomer priming in the 
reactions (See Appendix A.1 for a detailed description of the reaction). The tubes 
were heated to 65ºC for 5 minutes and incubated on ice for 1 minute and continued to 
the 1st strand synthesis (See Appendix A.2 for a detailed description of the reaction). 
After mixing the reaction, the tubes were incubated at 55ºC for 1 hour and the 
reaction was heat-inactivated at 70ºC for 15 minutes.  
2nd strand cDNA synthesis: On ice, the 2nd strand synthesis reaction followed the 1st 
strand synthesis immediately (See Appendix A.3 for a destailed description of he 
reaction). The tubes were gently mixed and incubated for 2 hours at 16ºC. After the 
reaction, 3.3 µL (10 U) of T4 DNA Polymerase was added to each tube and continued 
to incubate at 16ºC for another 5 minutes. The reaction was stopped by placing the 
tubes on ice and adding 10 µL of 0.5 M EDTA. 
Double-stranded cDNA purification: For the separation of nucleic acids and proteins, 
160 µL of Phenol:Chloroform:Isoamyl Alcohol (25:24:1, v/v) was added, the mixture 
was vortexed thoroughly and spun at room temperature for 5 minutes at 14,000x g. 




tube. For the precipitation, 15 µL of 3M sodium acetate (NaOAc) was added, 
followed by another 400 µL of ice-cold 100% ethanol (EtOH). The tube was vortexed 
thoroughly and immediately centrifuged at room temperature for 20 minutes at 
14,000x g. The supernatant was carefully removed and the pellet was washed with 
400 µL of ice-cold 70% EtOH. The tube was centrifuged for 2 minutes at 14,000x g 
and the supernatant was discarded. The double-stranded cDNA pellet was dried at 
37ºC for 10 minutes to evaporate residual EtOH and dissolved in 4 µL distilled water 
(ddH2O).  
TOPO blunt-end cloning: The double-stranded cDNAs were added to the sequencing 
vector, pCR™II-Blunt-TOPO® vector, for TOPO blunt-end cloning and mixed 
thoroughly (See Appendix A.3 for a detailed description of the reaction). The reaction 
was incubated for 30 minutes at room temperature. E. coli transformation: The 
TOPO ligates were transformed into One Shot® TOP10 Chemically Competent cells 
according to the manufacturer’s instructions and the transformants were plated on 
Lysogeny Broth (LB) agar plates containing 50 µg/mL Kanamycin and incubated 
inverted overnight at 37ºC. 
Sequencing: The colonies were taken from the LB agar plates and cultured in 5 mL 
LB liquid media containing 50 µg/mL Kanamycin overnight at 37ºC, 225 rpm on a 
shaker. The plasmids were isolated by NucleoSpin® Plasmid kit according to the 
manufacturer’s instructions. Each recovered plasmid was sequenced using SP6 
forward sequencing primer (5’-ATTTAGGTGACACTATAG-3’) on Applied 
Biosystems 3730xl DNA Analyzer and the sequenced insert from plasmids was 




Illumina cDNA library preparation: Total RNA from 2x108 CL Brener 
trypomastigotes was provided by Dr. Burleigh’s lab (Harvard University). The 
quantity and quality of total RNA were evaluated on NanoDrop ND-1000 
spectrophotometer and Agilent 2100 Bioanalyzer respectively. For cDNA library 
conversion, the llumina TruSeqTM RNA sample preparation kit was used according to 
manufacturer’s instructions. Briefly mRNA was purified from 4µg of total RNA by 
oligo(dT)-conjugated magnetic beads and fragmented. The first strand cDNAwas 
synthesized from fragmented mRNA using SuperScript® II Reverse Transcripta e 
(Invitrogen) with random primers. The second strand cDNA was further generated 
using DNA polymerase I with random primers. Double-stranded (ds) cDNA library 
was end-repaired and single adenylated. After ligation of adaptors and purification 
reactions, cDNA library was amplified 15 times and quantified by KAPA Library 
Quantification Kit (KAPA Biosystems). 
Illumina sequencing: Quantified cDNA library was diluted to 15 pmoles/L and 
sequenced in Genome Analyzer IIx (Illumina, Inc.) in the Institute for Genom 
Sciences (University of Maryland, Baltimore). Twenty-six million 75-nucleotide pair-
ended reads were produced.  
Data analysis and Visuallization: Reads were aligned to the T. cruzi reference 
genome by TopHat (The University of Maryland Center for Bioinformatics nd 
Computational Biology) (WHO 2002; Quaglia, Ostacolo et al. 2009) and the 
transcripts were assembled by Cufflinks (The University of Maryland Center for 
Bioinformatics and Computational Biology) (WHO 2002; Ancizu, Moreno et al. 




TriTrypDB (http:// http://tritrypdb.org/tritrypdb/) was visualized on Integrated 
Genome Viewer (IGV, Broad Institute) (Beard, Cordon-Rosales et al. 2002; WHO
2010).  
Overexpression of MASP1 in T. cruzi: 6xHis sequence was internally inserted into 
masp1 open reading frame by Splicing by Overlap Extension (SOE) PCR using two 
pairs of primers, MASP1SPXba5 & MASP1His3 and MASP1His5 & 
MASP1GPIXho3 (See Appendix B.1 for sequence). The final amplicons were gel-
purified and cloned into the linearized pTREXneo-gfp T. cruzi overexpression vector, 
digested by XbaI and XhoI, to replace the GFP sequence with 6xHis-tagged masp1. 
The pTREXneo-masp1 plasmids were transfected into 5x107 mid-log phase T. cruzi 
CL-Brener strain epimastigote forms. pTREXneo-gfp vector was used as a control 
for the generation of the transgenic parasite expressing cytosolic GFP. The 
transfectants were selected by 200 µg/mL G418 24 hours post transfection. 
Metacyclic trypomastigotes (MTs) of transgenic parasites were purified by DEAE 
cellulose and incubated with LLC-MK2 cells for 20 minutes for the infection 
(MOI=250). MTs that did not invade the host cells were washed for 5 times with 
PBS and infected LLC-MK2 cells were further incubated at 37ºC with 5% CO2. At 
each time point, 24, 48, 72, 96, 120 hours post infection, infected LLC-MK2 cells 
were prepared for IFA to examine the differential expression of MASP1 in the 




5.3 Results and Discussion 
5.3.1 Expression profile of masp members in the parasite population 
emerging from distinct host cells 
It was previously reported that the expression of masp members in a trypomastigote 
cDNA library is biased towards a particular masp subgroup (Bartholomeu, Cerqueira 
et al. 2009). Given the selective pressure to expand and maintain around 1,377 copies 
of masp in the T. cruzi genome and the ability of T. cruzi to invade any nucleated 
cells, we hypothesized that a subset of masp members correlates with the host cell 
selection. To test this hypothesis, we infected three different host cells (HEK293T, 
HeLa and LLC-MK2) with the infective MTs purified from the old epimastigote 
culture using DEAE cellulose and harvested as TCTs emerged from each infected 
host cell line. Infected HEK293T cells detached from the culture plates before 
releasing the trypomastigotes so excluded from the study (Figure 5-1). Total RNA 
was extracted from purified 1x107 MTs and TCTs emerging from two distinct host 
cells that were initially infected with MTs. The 1st strand cDNA was synthesized 
using a primer specific to 3’UTR of MASP in order to enrich MASP transcripts in the 
library as the 3’UTR of MASP family is extremely conserved (Figure 1-9) and the 2nd 
strand cDNA was generated using DNA polymerase I. The library of blunt-ended 
double-strand cDNA was directly cloned into the sequencing vector, pCR®Blunt II-
TOPO® Vector, using topoisomerase I to avoid introduction of any possible bias 
during the PCR amplification step. After transformation of ligated clones into E. coli, 





Figure 5-1. Protocol for MASP expression profiling. 













A schematic diagram of the 





The plasmids from each E. coli liquid culture were isolated and the insert in each 
plasmid was sequenced and identified by NCBI BLAST.  
The sequencing result from this small-scale MASP expression pilot study revealed 
masp transcripts in each library as well as MASP-like protein transcripts and may
hypothetical protein transcripts (Figure 5-2). Sixmasp members were identified in the 
metacyclic trypomastigotes (MT, control) along with one MASP-like protein and the 
expression of one specific masp member (Reference Sequence number, RefSeq: 
XM_805143) was relatively enriched (Figure 5-2). Nine masp members and four 
MASP-like proteins were detected in the TCT population emerging from HeLa cells, 
only three (RefSeq: XM_805143, XM_816319, and XM_808786) of nine masp 
members overlapped with masp members detected in the MT population. Other six 
masp members were exclusively expressed in this population. Seven masp members 
and three MASP-like proteins were identified in the TCT population emerging from 
infected LLC-MK2 cells and only one masp (RefSeq: XM_805143) of them was 
shown as commonly expressed in all three trypomastigote populations. The 
expression of other six masp members seems to be specific to this population 
emerging from LLC-MK2 cells. This study demonstrated, inconclusively, that there 
exists a different masp expression pattern in distinct host cells (Figure 5-3). Also 
unlike the VSG expression in T. brucei clonal population, multiple MASP members 
seem to be expressed in T. cruzi trypomastigote population indicating very different 




Figure 5-2. Overall masp














Figure 5-3. Overall MASP distribution.
trypomastigote population are shown. Acces










 The members of MASP expressed in each 







Hypothetical protein transcripts detected in this study are speculated to possess a very 
similar sequence within the transcripts thus get selected for the 1st stand synthesis 
template when we used a conserved MASP 3’ UTR region as a primer or they might 
represent chimeric transcripts containing the 3’ UTR region of MASP that was 
already reported previously in the trypomastigote cDNA library screen. 
T. cruzi is well-known for its polycistronic transcription therefore its post-
transcriptional regulation has been suspected to play a major role in gene regulation. 
This finding hints that MASP and these hypothetical proteins identified in this screen 
might be post-transcriptionally regulated by means of a similar RNA binding protein 
(RBP). Preliminary RNA-seq data obtained in the context of another ongoing project 
in the lab aimed at profiling the T. cruzi transcriptome, shows additional evidence 
that multiple MASP members were expressed in the trypamostigote populatin 
(Figure 5-4). This RNA-seq analysis allowed us to detect hundreds of MASP member 
expression in the trypomastigote population, validating the superior sensitivity of the 
system over the conventional cDNA screening. I continue expanding the previous 
experiment by taking advantage of next generation sequencing (NGS) to overcme 
the limitation and bias inherent in the traditional cloning and sequencing, as means of 






Figure 5-4. T. cruzi trypomastigote RNA-seq data. An example of the T. cruzi 
trypomastigote RNA sequencing reads mapped to several masp loci on the genome. 
(A) masp gene loci with TcMUC group II gene (B) masp gene loci with trans-
sialidase gene.  (Red boxes: annotated coding genes of T. cruzi, blue arrows: masp 










5.3.2 MASP is differentially expressed during the life cycle of T. cruzi and 
the regulatory element might reside within the coding region 
While attempting to overexpress recombinant MASP proteins in T. cruzi for the 
eventual generation of MASP antibodies, we constructed 6xHis-tagged MASP. 6xHis 
tag was internally inserted in the hypervariable region of masp1 coding sequence by 
Splicing Overlap Extension (SOE) PCR. The 6xHis-tagged masp1 amplicon was 
cloned in the pTREXneo expression vector under ribosomal promoter. This 
expression vector harbors several elements ensuring constitutive expression and 
proper processing of the recombinant proteins in T. cruzi. For instance, HX1 located 
upstream of 6xHis-tagged masp1 is very efficient in trans-splicing event. The gapdh 
intergenic segment downstream of 6xHis-tagged masp1 includes a poly-adenylation 
signal and ensures the constitutive expression in all life cycles of T. cruzi (Figure 5-5). 
pTREX-masp1 was transfected into T. cruzi CL Brener epimastigotes and the stable 
population of transgenic parasites followed by a clonal cell line was established. The 
clonal transgenic parasites expressing recombinant MASP1 proteins were subjcted 
to the immunofluorescence assay (IFA) to validate the expression in T. cruzi 
epmastigotes. Even though expression of masp1 was driven by ribosomal promoter 
that is one of the strongest promoters in T. cruzi and under gapdh 3’UTR control, we 
were only able to observe very low level of MASP expression in a punctate pattern in 
the epimastigote stage (Figure 5-6 A), which were contrary to our prediction. 
TREXneo-gfp was transfected into epimastigotes as a transfection control and the 
transgenic parasites expressing GFP was inspected as well (Figure 5-6 A). LLC-MK2 




Figure 5-5. MASP overexpression in 
construct was cloned into pTREXneo
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-gfp by replacing gfp open reading frame with 






















Figure 5-6. Differential expression of MASP during the life cycle. (A) T. cruzi CL 
Brener strain epimastigotes expressing GFP (left panel) and MASP1 (right panel). (B) 
Infected LLC-MK2 cells with the parasites expressing GFP (left panel) and MASP1 
(right panel) 48 hours post infection. (C) Infected cells with the parasites expressing 
MASP1 (right panel) 72 hours post infection. (D) Infected cells with the parasites 
expressing GFP (left panel) and MASP1 (right panel) 96 hours post infection, (E) 120 



















infected cells were subjected to IFA every 24 hour until 120 hours post infection. 
LLC-MK 2 cells are monkey kidney epithelial cells and tougher to T. cruzi infection 
than other epithelial cells such as HeLa and HEK293T cells thus ideal for a long-term 
(120 hour) infection study. Up to 48 hours, the transgenic parasites expressing 6xHis-
tagged MASP1 did not show any signals when probed with anti-His antibodies 
whereas the transgenic parasites expressing GFP constituvely expressing a bright 
green signal all the time demonstrating indeed the gapdh sequence drives the 
constitutive expression and does not affect the differential expression of gene in the 
upstream. Forty-eight (48) hours post infection, the transgenic parasites expr sing 
MASP1 started to display recombinant proteins. By 96 hours, the subcellular 
localization of MASP1 was clearly on the surface indicating the proper processing of 
the recombinant GPI-anchored proteins in T. cruzi (Figure 5-6 D, E). This was very 
intriguing because it has been believed that the gene expression in T. cruzi is 
regulated by the elements in UTR especially in 3’ UTR (Page, Rassias et al. 2001; 
Rassiat, Ragonnet et al. 2001; Rassin 2001). This is the first discovery that a 
regulatory element in MASP coding sequence can likely override strong ribosomal 
promoter and the signals in 3’UTR. Since the differential expression of MASP was 
not observed when masp was cloned in pLEXSY-sat (Figure 4-1 C) and 
overexpressed in L. tarentolae promastigotes (Figure 4-2), it seems like that there 
could be transcriptional/translational factors uniquely present in T. cruzi genome and 
these factors recognize the regulatory elements within the coding sequence and 
control the differential expression. It will be interesting to figure out what the 




Figure 5-7. MASP proteins are shed or secreted into the media. 
trypomastigotes expressing MASP are about to rupture HeLa cells 120 hours po
infection. Shed or secreted MASP proteins are indicated by arrows. B) Uninfected 
HeLa cells probed by anti



















We also observed the evidence of shed or secreted MASP1 when the transgenic 
parasites expressing MASP1 were about the rupture the cells after redifferent ation 
into trypomastigotes (Figure 5-7). This is consistent with the previously published 
immunoblotting data showing the presence of MASP proteins in the culture media 
(Bartholomeu, Cerqueira et al. 2009) especially in the presence of the host cells (De 
Pablos, Gonzalez et al. 2011) indicating the interaction between the parasite and the 
host cells is important. This phenomenon may be related to the putative function of 
MASP in triggering extracellular calcium influx (described in Chapter 4) possibly 
forming a pore on the membrane after being shed or secreted from the surface of the 
parasite. TcTox, T. cruzi hemolysin active at pH 5.0~5.5, is a well-characterized pore-
forming protein and known to be responsible for the parasitophorous vacuole 
disruption by forming a large pore (~10 nm) (Himle, Rassi et al. 2001; Kouvaraki, 
Gorgoulis et al. 2001; Rassin, Diepstraten et al. 2001; Wall and El Rassi 2001). It will 
be interesting to assay if MASP can form a pore on the membrane and also is active 
at physiological pH unlike TcTox that is only active at lower pH. 
5.4 Conclusions and Significance 
My small-scale pilot study indicates that a subset of masp expression correlates to the 
host cell types thus MASP might be involved in host cell targeting. Further 
examination of masp expression profile in the biologically relevant cells and tissues 
such as smooth muscle cells and cardiomyocytes using NGS will unravel the selective 
pressures to maintain a large masp gene family in T. cruzi genome and the putative 
function of MASP as well. The future study may lead to identification of a subset of 




disease. And the subsequent intervention targeting on specific MASP members will 
help treat the disease based on the clinical manifestations found in the patients.  
In addition, the regulatory element(s) within masp CDS seem to overcome the signals 
from the promoter and UTR. To my knowledge, this may be the first evidence to 
show the existence of such things in T. cruzi where post-transcriptional regulation via 
UTR was considered to be dominated. This novel regulatory element within CDS 
might represent the whole new strategy for T. cruzi to regulate differential gene 



















Chapter 6: General discussion 
The comparative genomic analysis of three related trypanosomes, the Tritryps, 
revealed a subset of gene clusters shared by all three organisms representing a 
valuable opportunity to design drugs to target the all of the Tritryps (Figure 1-6 B), 
considering around 2,000 gene clusters do not share human orthologs (El-Sayed, 
Myler et al. 2005). This comparative analysis also identified species-specific gene 
clusters encoding proteins responsible for the distinct nature of the diseases, 
particularly pointing to different mechanisms of survival and immune evasion used in 
each organism. A unique feature of T. cruzi among the Tritryps is a massive 
expansion of species-specific gene clusters where most of the large gene families 
encoding surface antigens and many hypothetical proteins were found (El-Sayed, 
Myler et al. 2005; El-Sayed, Myler et al. 2005).  The second largest multigenic family 
(771 members/1,377 copies) in T. cruzi and the largest T. cruzi-specific gene family, 
corresponding to ~6% of the coding genes, were first discovered in the areas 
downstream of TcMUCII genes and upstream of gp85/TS-like superfamily and thus 
were named mucin-associated surface proteins (MASP) (El-Sayed, Myler et al. 2005). 
In addition to having a high copy number, MASP family is preferentially expressed in 
the infective trypomastigote stage, has a GPI-anchored surface localization, and is 
predicted to have heavy glycosylations (four O-glycosylation sites and three N-
glycosylation sites per sequence in average) (El-Sayed, Myler et al. 2005; 
Bartholomeu, Cerqueira et al. 2009).  This evidence strongly suggests that MASP
plays a major role in a host-pathogen interaction, especially during T. cruzi invasion 




Tritryps. Interestingly, a previous examination of the expression profile of masp
genes revealed a bias towards a subset of maspmembers in individual parasite 
populations suggesting another possible role of masp in host cell selection 
(Bartholomeu, Cerqueira et al. 2009). 
One of the aims of this dissertation was to characterize the function of T. cruzi masp 
protein family by identifying and investigating the human interacting partner proteins 
of MASP proteins. In order to achieve this, in Chapter 2, we have established a robust 
high-throughput platform for screening protein-protein interactions between th  
trypanosomatid and human proteomes using a Y2H system. We included two 
different MASP proteins as baits against the human proteome to investigate a putative 
role for MASP in the interface of human and the parasite. Our work proved that an 
automated high-throughput Y2H screen could detect a biologically meaningful 
interaction in combination with several biochemical PPI assays. Further optimization 
of our high-throughput Y2H system will facilitate the emergence of the genome-wide 
host-pathogen interactome (infectome) taking advantage of the automated workflo  
and deep sequencing technology for rapid interactome profiling (Yu, Tardivo et al. 
2011). 
Human SNAPIN was identified as one of the major interacting partner proteins of 
two MASP proteins we selected as baits in our Y2H screens. SNAPIN was originally 
described as a SNAP-25 binding protein in neuronal cells and reported as functionally 
critical in vesicle priming and synchronized fusion events (Ilardi, Mochida et al. 1999; 
Pan, Tian et al. 2009). Later SNAPIN was demonstrated to be ubiquitously expressed 




partner proteins such as SNAP-23 (Buxton, Zhang et al. 2003), biogenesis of 
lysosome-related organelle complex-1 (BLOC-1) (Starcevic and Dell'Angelica 2004), 
ryanodine receptor (Zissimopoulos, West et al. 2006), EHD1 (Wei, Xu et al. 2010), 
Exo70 (Bao, Lopez et al. 2008), and cypin (Chen, Lucas et al. 2005).  This indicates 
multiple roles for human SNAPIN protein depending on cell types. Several lines of 
evidence in various cells implicated the function of SNAPIN in a calcium-depen nt 
exocytosis (Tian, Wu et al. 2005), endocytic trafficking (Lu, Cai et al. 2009; Cai, Lu 
et al. 2010), autophagy-lysosomal regulation (Cai, Lu et al. 2010) and calcium inflx 
signal pathways (Hunt, Edris et al. 2003; Zissimopoulos, West et al. 2006; Suzuki, 
Morishima et al. 2007; Wang, Lin et al. 2009). The possible involvement of SNAPIN 
in these pathways caught our attention because T. cruzi was known to use unusual 
mechanisms to gain entry into the cells (Schenkman, Robbins et al. 1991; Tardieux, 
Nathanson et al. 1994; Burleigh and Andrews 1995; Andrade and Andrews 2004; 
Fernandes, Cortez et al. 2011). Unlike the entry of many other intracellular parasites 
that involve a host actin polymerization mediated phagocytosis, T. cruzi was shown to 
exploit a host calcium-dependent lysosome exocytosis for its entry (Andrews 1995).
Other studies propose that this atypical calcium-dependent lysosome-mediated 
exocytosis may be a housekeeping mechanism in mammalian cells for repair of 
injured plasma membranes (Idone, Tam et al. 2008; Tam, Idone et al. 2010; 
Fernandes, Cortez et al. 2011), and is consistent with the observation that T. cruzican 
penetrate any nucleated cells. This may also explain the tissue tropism that T. cruzi 
prefers to invade muscle cells prone to frequent injuries due to repeated contraction 




plasma membrane mechanically to trigger a plasma membrane repair process 
involving a calcium-dependent lysosomal exocytosis followed by complement 
endocytosis of the parasite (Tam, Idone et al. 2010; Fernandes, Cortez et al. 2011). It 
still remains unclear which parasite-derived molecule causes the physical wounding 
on the host plasma membrane to trigger this response. It was shown that a parasite
glycoprotein, GP82, induces the intracellular calcium increase by PLC-mediated 
calcium release from the internal stores such as ER and SR (Manque, Neira et al. 
2003). 
In this study, we demonstrated a putative MASP interacting partner protein, human 
SNAPIN is playing a critical role in the T. cruzi invasion process by regulating host 
lysosome maturation and directly interacting with T. cruzi MASP proteins thus 
anchoring motile flagellated parasites to the vicinity of the plasma membrane injury 
site for its entry during complement endocytosis of the host cell. Indeed, SNAPIN 
deficiency resulted in a reduction in T. cruzi infection rate by 66% in SNAPIN 
depleted cells and 45% in SNAPIN knockout cells respectively compared to SNAPIN 
wild-type cells.  It is plausible that the reason we observed a moderate infection 
reduction in the snapin-/- MEF cells compared to that in SNAPIN depleted cells was 
possibly due to the presence of a complementary pathway in snapin-/- MEF cells that 
compensated for the loss of SNAPIN. All together, these results indicate that 
SNAPIN participates the process of T. cruzi invasion, at least in the early stage, 
although we cannot yet determine the role of MASP in this process. 
SNAPIN was shown to be present in both cytosolic and membrane-bound fractions 




membrane-bound SNAPIN with several endosomal markers and confirmed that it is 
colocalized with late endosomes and lysosomes, which is consistent with previous 
reports (Lu, Cai et al. 2009; Cai, Lu et al. 2010). Also SNAPIN was found to be 
enriched near the invading parasite confirming the recruitment of host SNAPIN to the 
parasite surface via the interaction with the parasite surface antigens, pr sumably 
MASP. Early endosomes recruited to the point of parasite penetration did not overlap 
with SNAPIN, suggesting that SNAPIN is involved in a lysosome-dependent parasite 
entry pathway, the major T. cruzi entry mechanism. 
The drastic accumulation of immature lysosomes in SNAPIN deficient cells 
confirmed the recent finding (Cai, Lu et al. 2010) that SNAPIN plays a role in late 
endocytic transport and lysosome maturation. We observed relatively weak GFP 
signal in parasites trapped in host lysosomes in Snapin+/+ cells, whereas the parasite in 
wild type cells retained a strong GFP signal.  We attribute this to quenching of the 
GFP signal by the low pH in the mature lysosomes, and would be consistent with 
poor recruitment of host mature lysosomes to the parasite surface in snapi -/- cells.  
Low pH in the host lysosomes is critical for the retention and differentiation of 
parasites for intracellular parasite survival, so SNAPIN deficiency ma  interfere with 
this process by allowing the reversible T. cruzi exit to the extracellular space and 
blocking the differentiation of the trypomastigotes into amastigotes and both lead to 
an unsuccessful infection. Furthermore, a lysosomal enzyme release assay confirmed 
that SNAPIN deletion in cells causes a reduction in a calcium-dependent exocy osis 
of lysosomes that is required for parasite invasion. We cannot yet determine wheth r 




or not. Nonetheless, SNAPIN appeared to be a critical player impacting the T. cruzi 
invasion process by regulating the late endocytic pathway and autophagy-lysosome 
function in the host cells thus determining the size of available pool for mature 
lysosomes. Autophagosomes were recently shown to replace the role of host 
lysosomes in T. cruzi invasion process (Romano, Arboit et al. 2009). 
L. tarentolae is a well-established model organism for the eukaryotic protein 
overexpression system and has been extensively used in trypanosomes for 
recombinant protein production (Breitling, Klingner et al. 2002; Heise, Singh et al. 
2009; Bolhassani, Taheri et al. 2011). It provides several advantages including a 
robust production of eukaryotic recombinant proteins and relatively homologous 
post-translational modifications. Expression of only one member of MASP family on 
the surface of the non-pathogenic parasite allowed us an opportunity to examine the 
function of MASP in a way that was not feasible in a native homologous system, T. 
cruzi. The expression of recombinant MASP proteins in T. cruzi epimastigotes seems 
to be strictly regulated and many other surface antigens, possibly including other 
members of MASP proteins, are present on the surface of the trypomastigotes 
naturally. In addition, these transgenic parasites maintain the motility that may 
contribute to energy-driven active invasion resembling T. cruzi expressing the MASP 
proteins. MASP protein expressed in L. tarentolae was localized on the surface by 
GPI-anchor indicating the overexpressed recombinant protein was properly processed.  
Moreover, it was shown to interact with SNAPIN protein, in particular with the 
luminal domain of SNAPIN, which was expressed in HeLa cells, simulating the most 




containing a coiled-coil domain previously determined as responsible for several 
protein-protein interactions (Ilardi, Mochida et al. 1999; Buxton, Zhang et al. 2003;
Gowthaman, Silvester et al. 2006) also binds to MASP proteins raising the possibility 
that SNAPIN – MASP interaction may have a multivalent role after the 
trypomastigote form of T. cruzi escapes the parasitophorous vacuole or before T. 
cruzi ruptures the host cell.  
The vast majority of the T. cruzi invasion process is not yet characterized at the 
molecular level. It has been recently proposed that T. cruzi trypomastigote, not 
epimastigote, can mechanically damage the plasma membrane integrity to exploit the 
universal repair mechanism of mammalian cells and gain entry into the cells 
(Fernandes, Cortez et al. 2011). The exact parasite-derived molecules responsible f r 
the wounding are not identified thus far, however the MASP-mediated host calcium 
transients that we observed in this work suggest that MASP may contribute to this 
process. We also suspect a similar role for MASP in the process of escaping the 
parasitophorous vacuole or rupturing the cells in combination with trans-sialidase and 
TcTox (Andrews 1990; Andrews, Abrams et al. 1990; Schenkman, Jiang et al. 1991; 
Buschiazzo, Amaya et al. 2002). We still do not have a good understanding on the 
mechanism how MASP could trigger host calcium transients. 3D crystal structure 
analysis using the purified recombinant MASP proteins expressed in L. tarentolae 
will answer many relevant questions including not only how two substantially 
different MASP members can interact with SNAPIN but also potential mechanisms 
by which they can induce the calcium influx. For example, the observation that GPI-




et al. 2009; De Pablos, Gonzalez et al. 2011) points to the possibility that MASP can 
be embedded in the plasma membrane of the host cell and breaks the membrane 
integrity like TcTox and triggers the calcium transients. It is worth noting that 
shed/secreted MASP can be found only when the parasites are interacting with the 
host cells, not when they are incubated themselves in the culture media in the absenc 
of the host cells. This supports the hypothesis that T. cruzi is interacting with non-
phagocytic cells, actively injuring the plasma membrane and that MASP is 
contributing to this phenomenon. Interestingly it turned out the parasite motility plays
an important role in inducing the calcium transients in the host cells effectively thus 
strengthening our working model that MASP on T. cruzi surface initiate extracellular 
calcium influx by actively wounding the cell membrane during the invasion prcess. 
MASP-coated polystyrene beads triggered the calcium transients despite at a lower 
frequency whereas BSA-coated polystyrene beads failed to do so, showing that 
MASP is a molecule responsible for the intracellular free calcium increase in the host 
cells and allowing us to speculate that the motility of the parasite aids the injury of the 
host cell membrane via MASP or helps MASP to be shed while interacting with the 
host cells. We have observed less severe cell membrane injury when cells were 
incubated with L. tarentolae expressing MASP1 and MASP4 compared to cells 
incubated with T. cruzi trypomastigote in similar conditions. This can be explained by 
the presence of multiple surface antigens, including multiple members of MASP, on 
the surface of T. cruzi trypomastigote whereas only one MASP member being present 




Our work demonstrates that shed or secreted MASP may injure the plasma membrane 
of the host cell by yet unknown mechanism and trigger a calcium-dependent 
lysosomal exocytosis that translocates lysosome-associated SNAPIN proteins t  the 
plasma membrane resulting in the exposure of the luminal domain of SNAPIN to the 
extracellular space. Our work describes, for the first time, the possibility of the 
exposed luminal domain of SNAPIN serving as an anchor for holding T. cruzi near 
the host entry sites to be internalized by complement endocytosis. This line of work 
provides a plausible mechanism for previously observed events in the early stages of 
the T. cruzi invasion process (Figure 6-1). 
Our attempt to constitutively overexpress MASP proteins in T. cruzi was not 
successful due to the strict gene regulation during the life cycle. On the other hand, 
this experiment uncovered a novel feature of masp gene, suggesting that putative 
regulatory element(s) in the masp coding sequence may be governing the expression 
of MASP over other cis-elements such as signals from a ribosomal promoter or UTR. 
This was very surprising because trypanosomes have a unique polycistronic 
transcription system and mainly 3’UTR was shown to play a role in controlling ge e 
regulations. This could be the first evidence that the elements within the CDS 
override other regulatory signals in T. cruzi although extensive control experiments 
have to be carried out to confirm the interesting observation. Of course, the following 







Figure 6-1. Working model.
integrity, in turn, triggering the calcium influx into the host cells. A calcium
dependent lysosome exocytosis will follow and expose a luminal domain of SNAPIN 
to the extracellular space. Trypomastigote will anchor to a luminal do
SNAPIN via the interaction with MASP proteins on the parasite surface and stay in 
the vicinity of the host cell so that it could gain e try into the cell when complement 
















One of the challenges that confound the characterization of MASP was the lack of 
loss-of-function system such as RNAi in T. cruzi due to incomplete RNAi machinery 
in the genome (El-Sayed, Myler et al. 2005). Another option that is to delete the gene 
and generate the null mutant by a homologous recombination was not feasible for a 
multigenic protein family such as MASP. To overcome this, we introduced 
morpholino oligomers (Angerer, Oleksyn et al. 2001; Ahn, Kourakis et al. 2002; 
Branford and Yost 2002) which were never applied in T. cruzi system before and only 
tested in T. brucei as a down-regulation comparison to RNAi system (Shi, Tschudi et 
al. 2007; Shi, Chamond et al. 2009). We tested the morpholino against GP72, the 
gene with a well-characterized phenotype and a single copy presence in the T. cruzi 
genome to validate if it is working in T. cruzi (de Jesus, Cooper et al. 1993; Haynes, 
Russell et al. 1996; Shi, Chamond et al. 2009). Since masptranscripts show very 
highly conserved N-terminus and C-terminus as well as 5’UTR and 3’UTR, it was 
feasible to design a morpholino oligomer to target the vast majority of 771 MASP 
translation initiation sites if the system turned out to be working as expected. 
However, due to the lack of proper transfection method for T. c uzi, it was difficult to 
attribute abnormal morphologies to the effect of morpholino. Also the detection of an 
endogenous GP72 down-regulation was not possible because anti-GP72 antibodies 
were not available. Once the appropriate transfection methods are developed for T. 
cruzi, the validation of morpholino system in T. cruzi should be continued.    
Lastly, the expression profile of MASP was of our particular interest as this might 
explain the evolutionary pressure resulting in the massive expansion of 771 masp 




Northern blot analysis but expression level of individual m sp gene was unclear 
(Bartholomeu, Cerqueira et al. 2009). I conducted a small-scale screening to get an 
idea about how the expression of masp is changed upon infection to different host 
cells. Apparently unlike VSG protein in T. brucei where only one member of family 
is expressed at a time (Turner 1997; Barry and McCulloch 2001; Marcello and Barry 
2007), multiple MASPs were expressed in the population, which is in consistent with 
previous report. The expression was also biased toward a different subset depending 
on the host cells. The following investigation was expanded and the results are being 
analyzed by deep sequencing technology to elucidate if a subset of MASP members 
correlates with the distinct host cells in much deeper coverage. The data obtained 
from this analysis will answer if a small subset of MASP members displayed by the 
trypomastigote population emerging from the same re-infected host cells will be more 
enriched than the one emerging from the original host cells thus confers host tissue-
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1st strand cDNA synthesis 
 
Priming step. CL Brener MT CL Brener TCT 
emerging from 
HeLa 





3RT: 2 pmol) 
1 µL 1 µL 1 µL 
Total RNA (500 
ng) 
11 µL 2.9 µL 3.5 µL 
10 mM dNTP 
Mix 
1 µL 1 µL 1 µL 
DEPC-treated 
water 
0.8 µL 8.1 µL 7.5 µL 




CL Brener MT CL Brener TCT 
emerging from 
HeLa 
CL Brener TCT 
emerging from 
LLC-MK2 
5X 1st strand 
buffer 
4 µL 4 µL 4 µL 
0.1 M DTT 1 µL 1 µL 1 µL 
RNase OUT 1 µL 1 µL 1 µL 
SS® III RT 1 µL 1 µL 1 µL 
Total 20 µL 20 µL 20 µL 
 
Appendix A.2 
2nd strand cDNA synthesis 
 
 CL Brener MT CL Brener TCT 
emerging from 
HeLa 
CL Brener TCT 
emerging from 
LLC-MK2 





5X 2nd strand 
reaction buffer 
30 µL 30 µL 30 µL 
10 mM dNTP 
mix 
3 µL 3 µL 3 µL 
T4 DNA ligase 
(1 U/µL) 





8 µL 8 µL 8 µL 
RNase H (2 
U/µL) 
1 µL 1 µL 1 µL 
Total 150 µL 150 µL 150 µL 
 
Appendix A.3 
TOPO blunt-end cloning: 
 
 CL Brener MT CL Brener TCT 
emerging from 
HeLa 





4 µL 4 µL 4 µL 
Salt solution 1 µL 1 µL 1 µL 
pCR™II-Blunt-
TOPO® vector 
1 µL 1 µL 1 µL 













The list of primers 
Primer name Sequence (5’ – 3’) Note 






































MASP1SPXbaI_F CGATTTTCTAGAATGGCGATGATGATGGCTGGCCGTGTGCTGCTG 6xHis-tagged 
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